Other diseases of intestine

K11_OTHINT

intestinal disease: A non-neoplastic or neoplastic disorder that affects the small or large intestine.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K63 Hospital discharge: ICD-9 — 569[5-9] Hospital discharge: ICD-8 — 569 Hospital discharge: excluded ICD-8 — 5690[6-7] Cause of death: ICD-10 — K63 Cause of death: ICD-9 — 569[5-9] Cause of death: ICD-8 — 569 Cause of death: excluded ICD-8 — 5690[6-7] 2 out of 7 registries used, show all original rules.	6485
4. Check minimum number of events None	6485
5. Include endpoints None	6485
6. Filter based on genotype QC (FinnGen only)	6254

Control definitions (FinnGen only)

Control exclude: K11_INTESTOTH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K55-K63
Name in latin: Alii morbi intestini

NAME	K11_OTHINT
CONTROL_EXCLUDE	K11_INTESTOTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K63
HD_ICD_9	569[5-9]
HD_ICD_8	569
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL	5690[6-7]
COD_MAINONLY
COD_ICD_10	K63
COD_ICD_9	569[5-9]
COD_ICD_8	569
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL	5690[6-7]
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other diseases of intestine based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	35557	18270	16907
Only index persons	28068	14716	13352
Unadjusted period prevalence (%)
Whole population	0.50	0.52	0.47
Only index persons	0.53	0.54	0.51
Median age at first event (years)
Whole population	64.22	65.59	62.79
Only index persons	63.47	64.36	62.49

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6254	3067	3187
Unadjusted period prevalence (%)	1.28	1.09	1.46
Median age at first event (years)	66.27	64.62	67.86

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6485: Matched controls
64846

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

23.6

318.8

230

101

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.5

308.0

822

2015

K65.0

ICD-10 Finland

Acute peritonitis

20.8

307.7

299

150

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

12.6

307.7

1150

1091

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

135.5

307.7

322

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

9.4

307.7

474

539

WX302

NOMESCO Finland

Thoracal epidural anesthesy

5.6

307.7

705

1382

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

14.2

307.7

336

248

JFB00

NOMESCO Finland

Partial resection of small intestine

31.4

307.7

426

145

JN3BD

NOMESCO Finland

Extensive abdominal CT

5.7

307.7

1139

2344

UJF30

NOMESCO Finland

Ileoscopy through colon

11.5

307.7

1584

1769

UJF32

NOMESCO Finland

Coloscopy

8.7

307.7

3096

6181

JAH00

NOMESCO Finland

Laparotomy

17.1

307.7

593

379

K63.5

ICD-10 Finland

Polyp of colon

619.1

307.7

3017

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

16384.0

307.7

1444

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

6.5

307.7

618

1033

K63.9

ICD-10 Finland

Disease of intestine, unspecified

183.8

307.7

477

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

27.4

307.7

2060

1082

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.9

307.7

2760

10288

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

356.9

307.7

464

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.4

307.7

2802

11921

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

7.3

307.7

983

1549

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

79.6

307.7

208

JN3AD

NOMESCO Finland

Abdominal CT examination

5.5

307.7

1335

2899

A06AC01

ATC

ispaghula (psylla seeds); oral

2.9

307.1

1891

7971

K59.09

ICD-10 Finland

Constipation, unspecified

7.0

301.9

477

724

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

981.2

289.7

282

WX408

NOMESCO Finland

General anesthesy, balanced

2.7

288.2

2186

10223

P01AB01

ATC

metronidazole; oral, rectal

2.6

287.3

2799

14782

K63.8

ICD-10 Finland

Other specified diseases of intestine

415.2

280.8

280

56909

ICD-8 Finland

Other diseases of intestines and peritoneum, Unspecified

+∞

276.0

263

WX402

NOMESCO Finland

General anaesthesia

2.7

260.8

1792

7911

K63.2

ICD-10 Finland

Fistula of intestine

+∞

251.7

240

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.3

248.2

706

1807

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

21.6

245.3

183

K62.1

ICD-10 Finland

Rectal polyp

70.3

241.3

131

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

241.1

1824

8404

TPH07

NOMESCO Finland

Cathetrisation of artery

3.2

240.6

1131

4039

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

5.2

230.8

495

1006

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

5.8

227.9

437

802

ZXD05

NOMESCO Finland

Urgent procedure

2.4

222.6

2274

11964

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.6

221.2

441

839

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

25.4

220.2

154

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

5.6

218.3

430

809

K63.0

ICD-10 Finland

Abscess of intestine

+∞

214.8

205

UJF92

NOMESCO Finland

Capsular endoscopy

9.6

213.3

254

274

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.9

203.1

1096

4205

JFA70

NOMESCO Finland

Suture of small intestine

41.4

202.4

122

JFF10

NOMESCO Finland

Loop enterostomy

26.6

200.6

138

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

200.5

3408

21848

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.6

199.9

1375

5981

D64.9

ICD-10 Finland

Anaemia, unspecified

3.1

199.0

961

3462

K63.3

ICD-10 Finland

Ulcer of intestine

993.2

197.9

193

56908

ICD-8 Finland

Other diseases of intestines and peritoneum, Alii definiti

+∞

197.9

189

K50.0

ICD-10 Finland

Crohn disease of small intestine

13.2

195.8

187

145

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

21.8

195.3

145

A07EC02

ATC

mesalazine; oral, rectal

4.8

195.2

467

1039

A02BC02

ATC

pantoprazole; systemic

2.3

194.2

4682

34289

JHA00

NOMESCO Finland

Anal or perianal incision

41.1

187.1

113

K50.9

ICD-10 Finland

Crohn disease, unspecified

13.4

185.5

176

135

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.0

184.6

928

3412

K56.7

ICD-10 Finland

Ileus, unspecified

275.9

183.8

187

K92.1

ICD-10 Finland

Melaena

4.4

183.2

487

1177

K61.0

ICD-10 Finland

Anal abscess

40.3

182.9

111

6453

FHL

Radical surgery of hemorrhoids

88.6

182.5

Z93.3

ICD-10 Finland

Colostomy status

15.5

182.3

159

105

JFB30

NOMESCO Finland

Right hemicolectomy

9.8

180.3

211

222

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.5

179.8

672

2066

K50.8

ICD-10 Finland

Other Crohn disease

12.5

179.2

177

145

A07EA06

ATC

budesonide; oral, local oral

5.8

174.9

328

588

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

172.7

1417

6653

ZXE00

NOMESCO Finland

One hour or less

2.1

172.7

2730

16733

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

5.7

169.2

324

592

JFB46

NOMESCO Finland

Resection of sigmoid colon

14.7

169.1

152

106

K59.1

ICD-10 Finland

Functional diarrhoea

5.1

168.9

370

763

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

6.2

167.7

296

500

R4110

NOMESCO Finland

Physiotherapy

2.2

165.5

2088

11708

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

4.8

164.8

383

830

UJG02

NOMESCO Finland

Proctoscopy

8.2

162.0

218

274

N02AX02

ATC

tramadol; systemic, rectal

2.0

160.8

3005

19422

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

160.0

2601

15987

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

5.9

157.6

288

503

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

6.0

156.0

283

491

JFF13

NOMESCO Finland

Terminal enterostomy

42.4

153.5

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

6.2

152.8

266

443

JAH01

NOMESCO Finland

Laparoscopy

4.5

151.2

381

881

R10.0

ICD-10 Finland

Acute abdomen

5.6

150.9

295

549

B01AB05

ATC

enoxaparin; parenteral

2.0

148.9

2312

13893

K59.0

ICD-10 Finland

Constipation

4.8

148.7

349

762

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

6.3

147.7

255

421

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

7.4

147.7

218

305

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

13.4

146.9

139

106

D01

ICPC

Abdominal pain/cramps general

3.0

142.3

716

2616

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

141.0

2664

17059

45599

ICD-8 Finland

Haemorrhoids

+∞

139.0

133

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.1

138.8

303

622

WX002

NOMESCO Finland

Sedation and analgesia

2.2

138.4

1453

7499

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

138.3

1124

5206

TJF80

NOMESCO Finland

Ostomy education

9.5

137.1

163

175

56902

ICD-8 Finland

Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)

+∞

136.9

131

J01MA02

ATC

ciprofloxacin; systemic

1.9

136.2

2670

17254

JFF23

NOMESCO Finland

Transversostomy

9.2

132.4

161

178

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

132.1

1145

5445

Z2221

NOMESCO Finland

Medical doctor

2.0

131.0

1864

10762

JFB20

NOMESCO Finland

Ileocaecal resection

22.1

130.3

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

5.4

129.6

260

495

K60.3

ICD-10 Finland

Anal fistula

169.7

126.9

133

K60.1

ICD-10 Finland

Chronic anal fissure

20.9

126.0

L04AX01

ATC

azathioprine; systemic

4.1

124.4

361

928

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

124.2

1056

4970

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

29.3

121.8

K50.1

ICD-10 Finland

Crohn disease of large intestine

10.9

119.5

129

121

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.9

118.4

363

970

WX892

NOMESCO Finland

Monitored bed care

2.8

117.8

642

2440

JN4AD

NOMESCO Finland

Body CT examination

2.5

117.5

847

3696

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.5

116.6

294

679

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

18.4

114.1

J01MA12

ATC

levofloxacin; systemic

2.1

114.1

1342

7177

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

113.8

784

3347

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

15.6

112.0

A06AD11

ATC

lactulose; oral

2.3

111.1

1003

4825

J01DB01

ATC

cefalexin; oral

2.1

111.0

5239

43565

ZX120

NOMESCO Finland

Intravenous

2.6

110.7

735

3081

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

8.8

110.3

139

161

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

110.2

873

3969

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

109.5

683

2777

N02BE01

ATC

paracetamol; systemic, rectal

2.4

109.3

5760

49774

JN4BD

NOMESCO Finland

Extensive body CT

2.4

108.7

839

3770

H02AB06

ATC

prednisolone; systemic

1.8

108.5

3113

22152

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

4.3

108.2

291

706

Z93.2

ICD-10 Finland

Ileostomy status

22.2

107.4

UJH02

NOMESCO Finland

Anoscopy

5.0

107.3

235

483

Z3226

NOMESCO Finland

Physiotherapist

2.1

106.9

1282

6886

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

8.2

106.6

142

176

N03AX16

ATC

[U] pregabalin

2.0

106.3

1541

8856

K56.0

ICD-10 Finland

Paralytic ileus

531.6

106.0

105

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

105.7

1354

7448

C03CA01

ATC

furosemide; systemic

1.8

104.9

2136

13693

D06

ICPC

Abdominal pain localized other

2.9

104.9

537

1970

JDA60

NOMESCO Finland

Closure of perforated ulcer of stomach

22.3

104.8

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

4.0

104.0

308

802

K57

ICD-10 Finland

Diverticular disease of intestine

8.7

102.3

130

152

K62.3

ICD-10 Finland

Rectal prolapse

37.4

101.7

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.7

101.2

332

929

C10AC01

ATC

colestyramine; oral

5.0

100.7

220

451

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

12.4

100.1

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

5.4

99.8

200

380

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

99.6

843

3935

UJD02

NOMESCO Finland

Gastroscopy

3.4

98.1

373

1149

A02BC05

ATC

esomeprazole; systemic

1.8

97.6

2541

17423

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

97.5

1256

6901

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

7.4

96.4

141

195

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

94.8

1133

6053

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

26.3

94.1

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.7

94.0

542

2113

JAH33

NOMESCO Finland

Opening of laparostomy

46.2

93.4

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

6.0

93.3

166

282

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

9.2

92.9

113

125

JF1BD

NOMESCO Finland

Very extensive small bowel CT

18.2

92.4

R50.9

ICD-10 Finland

Fever, unspecified

2.1

92.3

986

5046

JFH10

NOMESCO Finland

Total colectomy and ileostomy

28.8

89.7

Z71.8

ICD-10 Finland

Other specified counselling

1.8

89.5

1837

11694

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

6.0

88.9

158

268

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

880.5

88.9

K51.5

ICD-10 Finland

Left sided colitis

4.7

88.6

208

453

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

7.2

88.3

131

184

S18

ICPC

Laceration/cut

1.7

87.8

2972

21700

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

86.7

2190

14768

D16

ICPC

Rectal bleeding

5.0

86.6

189

387

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.7

86.3

283

791

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

85.9

1418

8428

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.1

85.8

184

371

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

85.0

1113

6122

JFB50

NOMESCO Finland

Other resection of colon

22.3

84.5

JAK03

NOMESCO Finland

Laparotomy and peritoneal irrigation

35.6

84.4

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.9

84.3

428

1559

R11

ICD-10 Finland

Nausea and vomiting

2.6

83.8

541

2227

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

83.7

4291

34717

JFB43

NOMESCO Finland

Left hemicolectomy

14.3

82.6

K25.1

ICD-10 Finland

Gastric ulcer, Acute with perforation

14.8

81.0

UJF30, ,

SPAT

7.9

79.1

108

138

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

78.8

653

3006

JF1AD

NOMESCO Finland

Small bowel CT

15.1

78.5

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

78.2

1183

6812

D18

ICPC

Change in faeces/bowel movements

4.5

77.8

192

435

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

77.6

249

685

WX882

NOMESCO Finland

High dependency care

3.8

77.6

240

644

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

31.5

76.8

R4190

NOMESCO Finland

Nutritional therapy

3.4

76.0

284

864

Z3231

NOMESCO Finland

Registered nurse

1.7

75.5

1760

11521

N02AA05

ATC

oxycodone; systemic

1.9

75.4

1206

7062

R06.0

ICD-10 Finland

Dyspnoea

1.7

75.3

1667

10753

A02BC01

ATC

omeprazole; systemic

1.7

75.0

1688

10938

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

74.6

880

4648

WW500

NOMESCO Finland

Blood transfusion

3.1

74.4

323

1076

B82

ICPC

Anaemia other/unspecified

3.9

74.4

227

603

A28

ICPC

Limited function/disability NOS

1.9

74.4

1179

6880

B01AB10

ATC

tinzaparin; parenteral

2.2

74.2

716

3504

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

4.2

73.8

198

479

H02AB07

ATC

prednisone; oral

2.0

73.3

905

4856

SPAT1125

SPAT

Stoma care and guidance

4.9

72.7

160

330

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

6.1

72.5

126

209

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

72.3

2195

15365

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

72.3

458

1865

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

71.1

494

2100

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

71.1

1731

11432

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

36.9

70.6

JFA80

NOMESCO Finland

Suture of colon

26.0

70.6

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

24.0

70.0

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

69.7

611

2874

WVA20

NOMESCO Finland

Medicine administration

3.8

69.3

219

596

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

68.9

328

1151

K62.2

ICD-10 Finland

Anal prolapse

28.9

68.7

TKC20

NOMESCO Finland

Catheterisation of bladder

2.4

68.7

515

2265

N06AX21

ATC

duloxetine; oral

2.1

68.4

676

3335

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

18.8

68.3

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

68.1

3038

23232

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

68.0

1261

7701

TQW11

NOMESCO Finland

Vacuum treatment of wound

4.2

67.6

185

454

A07EA02

ATC

hydrocortisone; rectal

4.7

67.1

158

345

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

17.3

67.0

A41.9

ICD-10 Finland

Sepsis, unspecified

3.1

67.0

288

954

D11

ICPC

Diarrhoea

2.2

66.9

610

2914

R02

ICPC

Shortness of breath/dyspnoea

2.0

66.8

830

4453

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

10.7

66.3

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.5

66.0

165

378

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

12.1

65.1

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

5.7

64.9

121

215

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

15.1

64.8

K57.0

ICD-10 Finland

Diverticular disease of small intestine with perforation and abscess

+∞

64.7

M54.5

ICD-10 Finland

Low back pain

1.6

64.2

1997

13971

R53

ICD-10 Finland

Malaise and fatigue

1.7

64.1

1346

8500

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.1

63.5

133

263

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

63.4

2484

18341

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

63.0

845

4650

A29

ICPC

General symptom/complaint other

1.9

62.8

828

4529

A04

ICPC

Weakness/tiredness general

1.9

62.6

848

4680

M79.6

ICD-10 Finland

Pain in limb

1.6

62.6

2402

17636

A02BC03

ATC

lansoprazole; oral

1.6

62.6

1723

11681

C07AB07

ATC

bisoprolol; oral

1.5

62.5

3161

24687

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

62.4

1342

8523

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.6

62.3

365

1428

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

22.1

62.3

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.5

62.0

404

1665

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.3

62.0

239

741

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

61.9

2679

20198

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

6.3

61.8

104

167

K65.9

ICD-10 Finland

Peritonitis, unspecified

17.1

61.7

UKC02

NOMESCO Finland

Cystoscopy

1.8

61.7

1052

6247

K60.2

ICD-10 Finland

Anal fissure, unspecified

8.7

61.5

A01

ICPC

Pain general/multiple sites

2.2

61.4

573

2760

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.4

61.2

101

159

K56.2

ICD-10 Finland

Volvulus

603.8

60.8

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.6

60.6

203

575

N06AX11

ATC

mirtazapine; oral

1.6

60.4

1944

13674

D12

ICPC

Constipation

3.4

60.2

218

650

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

59.8

882

5002

N05CF01

ATC

zopiclone; oral

1.6

59.7

1956

13809

B80

ICPC

Iron deficiency anaemia

4.0

59.0

169

429

WZC30

NOMESCO Finland

Teaching

1.8

58.7

1034

6191

R03AC02

ATC

salbutamol; inhalant

1.5

58.7

3145

24745

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

9.2

58.6

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

4.8

58.0

132

280

JHD20

NOMESCO Finland

Incision of fistula-in-ano

573.2

57.7

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

57.6

610

3081

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

3.9

57.4

170

442

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

57.3

884

5079

A06AC51

ATC

ispaghula, combinations; oral

2.9

57.3

273

958

K51.8

ICD-10 Finland

Other ulcerative colitis

5.5

56.7

110

203

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

16.9

56.5

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

22.9

56.3

L28

ICPC

Limited function/disability (L)

1.7

56.3

1118

6923

Z2446

NOMESCO Finland

Social worker

2.4

56.2

397

1697

J01FF01

ATC

clindamycin; systemic

1.6

56.1

1613

11005

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

6.7

55.9

135

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

7.2

55.4

115

5698C

ICD-9 Finland

Other disorders of intestine, Other specified disorders of intestine[PERFORATIO INTESTINALIS]

+∞

55.3

JFB40

NOMESCO Finland

Resection of transverse colon

18.5

55.2

TK800

NOMESCO Finland

Hemodialysis

3.7

54.8

175

480

J02AC01

ATC

fluconazole; systemic

1.6

54.8

2066

14999

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

4.3

54.7

142

335

JAD10

NOMESCO Finland

Repair of incisional hernia

7.6

54.7

102

K64.1

ICD-10 Finland

Second degree haemorrhoids

5.2

54.3

113

222

R03BB04

ATC

tiotropium bromide; inhalant

2.0

54.2

684

3675

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

54.2

438

1986

AA1AD

NOMESCO Finland

CT of head and brain

1.6

53.7

1697

11821

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

53.6

1589

10902

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

53.5

202

618

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

21.2

53.2

K26.1

ICD-10 Finland

Duodenal ulcer, acute with perforation

21.2

53.2

WX872

NOMESCO Finland

Intensive care

2.4

52.9

388

1686

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

10.3

52.8

L01BC06

ATC

capecitabine; oral

2.7

52.6

300

1158

UJF02

NOMESCO Finland

Peroral enteroscopy

9.6

52.1

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.1

51.6

220

725

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.0

51.5

111

225

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

11.9

51.4

K64.0

ICD-10 Finland

First degree haemorrhoids

5.0

50.8

109

220

WX704

NOMESCO Finland

Intubation

2.1

50.5

517

2574

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.9

50.3

147

379

D92

ICPC

Diverticular disease

11.1

50.2

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.2

50.2

133

319

N06AX16

ATC

venlafaxine; oral

1.9

50.1

730

4109

S97

ICPC

Chronic ulcer skin

2.2

49.6

418

1927

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.5

49.1

170

492

K64.2

ICD-10 Finland

Third degree haemorrhoids

7.5

49.1

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

49.0

1550

10763

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

9.0

48.9

JFG36

NOMESCO Finland

Closure of terminal colostomy with anastomosis to rectum

171.3

48.9

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.5

48.7

313

1280

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

48.6

334

1409

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

48.3

1100

7041

N05BA04

ATC

oxazepam; oral

1.6

48.2

1443

9887

L03

ICPC

Low back symptom/complaint

1.6

48.1

1495

10330

K99

ICPC

Cardiovascular disease other

3.0

48.1

220

755

C08CA01

ATC

amlodipine; oral

1.5

47.9

2468

18994

K29.7

ICD-10 Finland

Gastritis, unspecified

2.9

47.8

232

822

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.5

47.8

326

1371

R15

ICD-10 Finland

Faecal incontinence

3.6

47.5

156

436

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

47.0

750

4339

K55.8

ICD-10 Finland

Other vascular disorders of intestine

+∞

46.9

56500

ICD-8 Finland

Anal fissure and fistula, Anal fissure

+∞

46.9

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.1

46.9

205

685

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.3

46.4

379

1724

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

46.1

399

1859

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

46.0

482

2419

R19.4

ICD-10 Finland

Change in bowel habit

3.5

45.9

161

470

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

45.9

261

1005

R51.80

ICD-10 Finland

Headache

1.8

45.8

755

4408

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

45.8

883

5398

D99

ICPC

Disease digestive system other

5.7

45.7

151

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

45.6

510

2621

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

5.9

45.6

141

K50

ICD-10 Finland

Crohn disease [regional enteritis]

17.7

45.5

ZXA05

NOMESCO Finland

Left side

1.6

45.2

1525

10712

C05AA08

ATC

fluocortolone; rectal, topical

1.8

45.1

734

4270

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

44.9

279

1123

K55.2

ICD-10 Finland

Angiodysplasia of colon

120.9

44.8

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

44.7

1840

13485

C03DA01

ATC

spironolactone; oral

1.8

44.6

768

4541

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

12.3

44.4

K59.01

ICD-10 Finland

Constipation outlet obstruction type

58.2

44.4

K30

ICD-10 Finland

Functional dyspepsia

1.9

44.2

583

3171

JKA20

NOMESCO Finland

Cholecystectomy

3.0

44.0

200

684

3AC01, ,

NOMESCO Finland

5.7

43.9

146

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

4.1

43.6

119

292

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.3

43.3

167

518

UJF34

NOMESCO Finland

Left colonoscopy

7.8

43.3

A02BA02

ATC

ranitidine; systemic

1.6

43.2

1115

7348

SPAT1262

SPAT

Handing over of treatment supplies

1.6

43.2

1109

7300

J01DA01

ATC

[U] cefalexin

1.4

43.0

3563

29776

JFA15, ,

SPAT

5.7

43.0

142

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

9.2

43.0

J01AA02

ATC

doxycycline; systemic

1.5

42.9

4703

41427

WX610

NOMESCO Finland

Patient controlled analgesia

7.1

42.7

B01AF02

ATC

apixaban; oral

1.7

42.6

826

5049

J01MA14

ATC

moxifloxacin; systemic

1.9

42.6

547

2948

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

56.0

42.4

WX320

NOMESCO Finland

Spinalanesthesy

1.5

42.3

1463

10314

K61.1

ICD-10 Finland

Rectal abscess

420.4

42.2

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.4

42.1

108

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.9

42.1

189

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

42.0

825

5059

ZXA00

NOMESCO Finland

Right side

1.5

42.0

1618

11669

N03AX12

ATC

[U] gabapentin; oral

1.7

41.9

905

5695

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

41.7

686

3998

E87.6

ICD-10 Finland

Hypokalaemia

2.7

41.7

232

884

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.1

41.6

172

557

D94

ICPC

Chronic enteritis/ulcerative colitis

7.5

41.5

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

41.5

288

1220

G47.3

ICD-10 Finland

Sleep apnoea

1.6

41.5

1321

9137

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

41.3

1043

6830

B03BA03

ATC

hydroxocobalamin; parenteral

2.2

41.3

375

1781

JEA00

NOMESCO Finland

Appendectomy

2.2

41.2

343

1572

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

6.1

41.2

117

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

41.1

588

3281

L29

ICPC

Musculoskeletal sympt/complt other

1.9

41.1

514

2744

M04AA01

ATC

allopurinol; systemic

1.7

41.1

854

5318

130

Kela drug reimbursment

Malignant tumour

1.8

41.1

614

3475

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.4

41.0

103

237

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

40.9

445

2262

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

3.3

40.9

153

466

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

5.3

40.7

153

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

40.7

2307

17928

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4.3

40.7

106

251

R03DC03

ATC

montelukast; oral

1.7

40.7

870

5458

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

40.4

1129

7571

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

6.9

40.2

H02AB04

ATC

methylprednisolone; systemic

1.7

40.2

824

5110

L17

ICPC

Foot/toe symptom/complaint

1.5

40.1

1621

11789

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.8

40.1

122

324

A04AA01

ATC

ondansetron; systemic, rectal

2.0

39.9

488

2585

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

39.8

290

1255

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

39.6

3889

33273

A91

ICPC

Abnormal result investigation NOS

2.3

39.5

316

1424

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.2

39.5

106

257

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

4.7

39.4

196

WW200

NOMESCO Finland

Immunization

2.9

39.2

187

657

A11CC03

ATC

alfacalcidol; systemic

3.0

38.8

169

564

H02AB09

ATC

hydrocortisone; systemic

3.2

38.7

156

497

JF2BD

NOMESCO Finland

Extensive colon CT

7.8

38.7

JF2AB

NOMESCO Finland

Colongraphy with X-ray

11.9

38.5

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

4.2

38.5

103

249

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

38.4

303

1358

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

38.1

1046

6975

SPAT1255

SPAT

Intravenous administration of medicine

2.0

38.0

424

2174

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

38.0

689

4126

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

4.4

38.0

214

B81

ICPC

Anaemia vit B12/folate deficiency

2.4

37.8

258

1084

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

37.8

556

3128

G04CA02

ATC

tamsulosin; oral

1.5

37.8

1508

10917

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

37.7

1523

11050

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

37.7

401

2022

WGA11

NOMESCO Finland

Planning of pain management

8.4

37.7

1470

FHL

Rectoscopy

11.9

37.6

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

37.6

386

1920

XF404

NOMESCO Finland

Ambulatory ECG

1.9

37.6

543

3037

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

37.6

633

3711

E0000UV, ,

ATC

1.4

37.1

2274

17850

N05BA01

ATC

diazepam; systemic, rectal

1.7

37.0

720

4395

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

37.0

1099

7461

127

Kela drug reimbursment

Transplant complication

3.8

37.0

111

292

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

7.0

36.8

K64.3

ICD-10 Finland

Fourth degree haemorrhoids

13.0

36.5

R52.2

ICD-10 Finland

Other chronic pain

2.7

36.5

207

796

4550A

ICD-9 Finland

Haemorrhoids, Internal haemorrhoids without mention of complication

+∞

36.5

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

36.5

239

986

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

36.4

461

2470

S21

ICPC

Skin texture symptom/complaint

1.7

36.3

829

5280

Z93

ICD-10 Finland

Artificial opening status

9.4

36.2

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

36.0

1419

10230

J01FA06

ATC

roxithromycin; oral

1.4

36.0

2225

17463

R42

ICD-10 Finland

Dizziness and giddiness

1.5

35.9

1275

8997

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

35.9

1405

10117

K62.6

ICD-10 Finland

Ulcer of anus and rectum

8.1

35.8

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

35.8

997

6665

Z43.3

ICD-10 Finland

Attention to colostomy

12.6

35.8

N30.0

ICD-10 Finland

Acute cystitis

1.6

35.5

822

5250

WX730

NOMESCO Finland

Conventional respirator

3.5

35.4

120

343

R31

ICD-10 Finland

Unspecified haematuria

1.8

35.4

625

3711

R35

ICD-10 Finland

Polyuria

2.0

35.4

397

2040

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.7

35.3

190

712

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

35.2

363

1808

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

35.1

618

3666

R06AE07

ATC

cetirizine; oral

1.4

34.9

2325

18459

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.2

34.9

137

R96

ICPC

Asthma

1.8

34.8

541

3094

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9.2

34.7

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

4.4

34.5

197

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

6.5

34.4

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

34.3

302

1415

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

34.2

836

5409

L04AD02

ATC

tacrolimus; systemic

4.7

34.2

170

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.3

34.2

127

385

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

34.0

276

1251

R52.9

ICD-10 Finland

Pain, unspecified

1.8

34.0

514

2915

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

33.9

1489

10950

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

33.8

1368

9897

R63.4

ICD-10 Finland

Abnormal weight loss

2.5

33.8

226

941

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

4.7

33.8

164

J01CA04

ATC

amoxicillin; systemic

1.4

33.6

4708

42178

N05AH04

ATC

quetiapine; oral

1.6

33.5

855

5592

WX290

NOMESCO Finland

Other blockage of nerve

1.4

33.4

2341

18708

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.0

33.4

363

1844

5698X

ICD-9 Finland

Other disorders of intestine, Other specified disorders of intestine[MORBUS INTESTINI ALIA DEFINITA]

+∞

33.4

K56.1

ICD-10 Finland

Intussusception

+∞

33.4

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

33.3

1100

7626

R52.0

ICD-10 Finland

Acute pain

2.7

33.2

186

711

D75

ICPC

Malignant neoplasm colon/rectum

5.0

33.1

140

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.9

33.0

160

567

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

33.0

381

1976

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

33.0

928

6207

L01BB02

ATC

mercaptopurine; oral

5.2

32.9

133

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

32.8

270

1232

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

32.6

1141

8005

T90

ICPC

Diabetes non-insulin dependent

1.5

32.6

1487

11002

A07DA03

ATC

loperamide; oral

2.5

32.6

212

872

4556A

ICD-9 Finland

Haemorrhoids, Unspecified haemorrhoids without mention of complication

+∞

32.3

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.4

32.2

223

944

K25.5

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with perforation

11.4

31.8

R01AD09

ATC

mometasone; nasal

1.4

31.6

2331

18739

D50

ICD-10 Finland

Iron deficiency anaemia

3.4

31.5

116

350

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.1

31.4

1370

FHL

Colonoscopy, whole colon

7.4

31.3

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

6.9

31.3

A27

ICPC

Fear of other disease NOS

2.1

31.1

293

1411

L04AA06

ATC

mycophenolic acid; systemic

3.2

30.8

121

380

K60.0

ICD-10 Finland

Acute anal fissure

7.6

30.5

WX199

NOMESCO Finland

Other local analgesia

2.4

30.4

222

962

M01AH01

ATC

celecoxib; oral

1.5

30.4

1009

6991

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

30.4

368

1940

M48.0

ICD-10 Finland

Spinal stenosis

1.6

30.4

712

4552

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

30.4

137

467

K62.0

ICD-10 Finland

Anal polyp

30.9

30.3

QBA10

NOMESCO Finland

Incision of skin of trunk

4.2

30.3

192

5608A

ICD-9 Finland

Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS ,ADHESIONES INTRAABDOMINALE]

+∞

30.2

K07

ICPC

Swollen ankles/oedema

2.1

30.2

290

1406

N02BF02

ATC

pregabalin; oral

2.1

30.2

306

1514

A11

ICPC

Chest pain NOS

1.8

30.1

450

2540

N18.8

ICD-10 Finland

Other chronic renal failure

2.6

30.0

170

654

D02

ICPC

Abdominal pain epigastric

2.1

29.9

302

1492

H05BX01

ATC

cinacalcet; oral

5.9

29.9

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

303.8

29.8

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

303.8

29.8

207

Kela drug reimbursment

Chronic arrhythmias

1.5

29.8

963

6633

R07.3

ICD-10 Finland

Other chest pain

1.7

29.8

531

3158

L04AC05

ATC

ustekinumab; parenteral

7.5

29.7

B01AA03

ATC

warfarin; systemic

1.5

29.6

1165

8356

R03BA05

ATC

fluticasone; inhalant

1.5

29.6

941

6458

N06AB04

ATC

citalopram; systemic

1.5

29.5

1089

7709

R74

ICPC

Upper respiratory infection acute

1.4

29.2

1387

10309

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.6

29.2

279

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

10.0

29.1

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

8.3

29.1

N06AA09

ATC

amitriptyline; systemic

1.7

29.0

517

3072

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

6.4

29.0

SPAT1254

SPAT

Administration of medicine

1.6

29.0

788

5218

B01AB04

ATC

dalteparin; parenteral

2.0

29.0

320

1634

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

28.9

291

1436

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

28.9

472

2735

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

28.8

1423

10652

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

28.7

394

2165

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

3.2

28.7

112

351

6451

FHL

Dilatation

103.9

28.7

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

10.7

28.6

A03FA02

ATC

cisapride; oral, rectal

1.9

28.6

393

2160

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

28.5

242

1118

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.4

28.4

163

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

28.4

462

2675

D15

ICPC

Melaena

8.6

28.4

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

28.2

707

4591

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

28.2

1476

11156

U71

ICPC

Cystitis/urinary infection other

2.0

28.2

329

1713

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

28.2

891

6102

D29

ICPC

Digestive symptom/complaint other

3.0

28.2

124

417

M25.5

ICD-10 Finland

Pain in joint

1.4

28.1

1623

12474

A99

ICPC

Disease/condition unspecnature/site

1.7

28.1

511

3053

I50.0

ICD-10 Finland

Congestive heart failure

1.8

28.1

439

2512

G44.2

ICD-10 Finland

Tension-type headache

1.7

28.0

617

3880

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

6.1

27.9

J01EA01

ATC

trimethoprim; systemic

1.4

27.8

1325

9842

S29

ICPC

Skin symptom/complaint other

1.5

27.7

1029

7285

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.1

27.7

287

1432

1490

FHL

Sigmoideoscopy (fiberscope)

9.7

27.6

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

27.6

538

3277

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

27.6

172

694

A46

ICD-10 Finland

Erysipelas

1.5

27.6

867

5929

R4120

NOMESCO Finland

Occupational therapy

1.9

27.6

367

1997

B01AC04

ATC

clopidogrel; oral

1.5

27.5

1003

7073

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

27.5

354

1906

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.8

27.5

410

2313

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

27.4

237

1103

E86

ICD-10 Finland

Volume depletion

2.7

27.4

149

562

JFF30

NOMESCO Finland

Other colostomy

35.2

27.4

K02.1

ICD-10 Finland

Caries of dentine

1.3

27.4

3091

26334

Z94.0

ICD-10 Finland

Kidney transplant status

4.1

27.3

181

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.7

27.2

149

564

ZY010

NOMESCO Finland

Hospital outpatient

2.2

27.2

237

1107

N32.1

ICD-10 Finland

Vesicointestinal fistula

10.4

27.1

G04BD12

ATC

mirabegron; oral

1.6

27.1

656

4223

A41.8

ICD-10 Finland

Other specified sepsis

2.9

27.1

125

432

R60.0

ICD-10 Finland

Localized oedema

1.6

27.0

681

4428

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

27.0

455

2661

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

27.0

147

555

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

26.9

160

631

A97

ICPC

No disease

1.5

26.9

946

6622

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

3.1

26.8

110

355

JWC00

NOMESCO Finland

Reoperation for deep infection in gastroenterological surgery

32.0

26.8

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.8

26.7

137

501

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

41.4

26.7

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

26.7

1159

8453

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

272.2

26.7

Z51.5

ICD-10 Finland

Palliative care

1.7

26.7

489

2928

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

26.6

187

797

U07

ICPC

Urine symptom/complaint other

1.8

26.6

393

2210

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.8

26.5

434

2517

R03BA02

ATC

budesonide; inhalant

1.5

26.5

912

6354

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

9.2

26.5

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

26.4

247

1186

A08

ICPC

Swelling

2.0

26.4

287

1458

A07AA11

ATC

rifaximin; oral

8.7

26.3

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

4.3

26.2

161

SPAT1263

SPAT

Sampling

1.3

26.1

2217

18074

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

5.8

26.1

D09

ICPC

Nausea

2.4

26.1

186

798

D25

ICPC

Abdominal distension

3.3

26.1

100

310

K63.4

ICD-10 Finland

Enteroptosis

+∞

26.1

L01

ICPC

Neck symptom/complaint

1.6

26.1

745

4985

ZXD20

NOMESCO Finland

Day surgery

1.6

26.0

699

4610

M01AB05

ATC

diclofenac; systemic, rectal

1.3

26.0

3789

33364

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

26.0

181

769

A12AA04

ATC

calcium carbonate; oral

3.2

26.0

101

316

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

7.4

25.8

X58

ICD-10 Finland

Exposure to other specified factors

1.6

25.7

710

4711

TQW40

NOMESCO Finland

Remowal of suture of skin

1.8

25.7

410

2358

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

25.7

218

1007

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

25.7

625

4026

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

25.7

367

2042

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

93.8

25.6

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

25.6

230

1087

K55.1

ICD-10 Finland

Chronic vascular disorders of intestine

135.6

25.6

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

25.5

257

1269

K62.7

ICD-10 Finland

Radiation proctitis

33.2

25.5

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

25.5

293

1517

E66.8

ICD-10 Finland

Other obesity

2.0

25.5

264

1318

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.0

25.3

272

1375

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

25.3

207

943

L04AB04

ATC

adalimumab; parenteral

2.9

25.2

118

411

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

25.2

291

1510

R5110, ,

SPAT

1.8

25.2

378

2136

C01DA14

ATC

isosorbide mononitrate; oral

1.5

25.1

906

6366

A07AA02

ATC

nystatin; oral

1.9

25.1

315

1680

R33

ICD-10 Finland

Retention of urine

1.7

25.0

454

2710

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

25.0

308

1633

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

25.0

420

2453

JAG60

NOMESCO Finland

Reconstruction of abdominal wall using prosthetic material

9.7

25.0

N05CF02

ATC

zolpidem; oral

1.5

24.8

882

6178

JHB00

NOMESCO Finland

Hemorrhoidectomy

2.6

24.7

141

545

XF402

NOMESCO Finland

ECG with work load test

1.6

24.7

597

3838

RD210, ,

NOMESCO Finland

3.1

24.7

101

326

XQ855

NOMESCO Finland

Skin temperature measurement

6.6

24.6

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

24.6

381

2172

N06AB03

ATC

fluoxetine; oral

1.6

24.6

596

3834

M10.9

ICD-10 Finland

Gout, unspecified

1.8

24.6

417

2442

6101

FHL

Exploratory laparotomy, includes possible biopases

6.8

24.6

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

4.9

24.5

112

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

24.5

1433

10998

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.4

24.5

175

752

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

24.4

474

2881

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

24.4

581

3721

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

24.4

1282

9662

L04AX03

ATC

methotrexate; systemic

1.7

24.4

517

3217

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

24.3

1580

12335

JAK00

NOMESCO Finland

Laparotomy and drainage of peritoneal cavity

22.0

24.3

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

20.1

24.3

N18.0

ICD-10 Finland

End-stage renal disease

3.7

24.2

207

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

24.2

2368

19652

JG1JB

NOMESCO Finland

Defekography with X-ray

7.3

24.1

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

24.0

2162

17724

56901

ICD-8 Finland

Other diseases of intestines and peritoneum, Perforatio intestini NUD

+∞

24.0

5621A

ICD-9 Finland

Diverticula of intestine, Colon[DIVERTICULOSIS COLI]

+∞

24.0

5650B

ICD-9 Finland

Anal fissure and fistula, Anal fissure[FISSURA ANI TYPICA]

+∞

24.0

U02

ICPC

Urinary frequency/urgency

1.6

24.0

694

4653

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.9

23.9

337

1866

L02

ICPC

Back symptom/complaint

1.7

23.9

456

2758

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

3.0

23.9

108

369

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

5.2

23.8

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

23.8

1540

12007

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

7.7

23.8

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

23.7

498

3090

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

23.7

222

1067

J01FA10

ATC

azithromycin; systemic

1.3

23.7

2971

25488

M03BX02

ATC

tizanidine; oral

1.3

23.7

3359

29295

H01

ICPC

Ear pain/earache

1.6

23.6

513

3211

Z00.8

ICD-10 Finland

Other general examinations

1.8

23.6

393

2289

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

4.0

23.6

170

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.8

23.5

115

411

JFF26

NOMESCO Finland

Sigmoidostomy

23.7

23.4

K29.8

ICD-10 Finland

Duodenitis

4.3

23.4

137

XG466

NOMESCO Finland

Sleep oxymetry

2.3

23.3

178

787

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

7.5

23.3

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

23.3

358

2036

K59.8

ICD-10 Finland

Other specified functional intestinal disorders

8.8

23.3

M01AE02

ATC

naproxen; oral, rectal

1.3

23.3

3010

25903

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

23.3

2962

25437

JF2AD

NOMESCO Finland

Colon CT

8.4

23.1

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.2

23.0

187

849

L08

ICPC

Shoulder symptom/complaint

1.4

23.0

1156

8637

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

23.0

240

1202

4553A

ICD-9 Finland

Haemorrhoids, External haemorrhoids without mention of complication

+∞

22.9

A07AA09

ATC

vancomycin; oral

3.4

22.9

249

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

22.8

1587

12501

N06AB10

ATC

escitalopram; oral

1.5

22.8

902

6447

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

22.8

596

3904

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.5

22.7

143

580

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

22.7

520

3299

A10AE04

ATC

insulin glargine; parenteral

1.6

22.7

553

3562

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

22.6

307

1680

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

22.6

197

920

JGC01

NOMESCO Finland

Laparoscopic rectopexy

25.9

22.6

A04AA02

ATC

granisetron; systemic, transdermal

1.8

22.6

380

2220

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

19.0

22.5

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

7.8

22.5

D91

ICPC

Abdominal hernia other

3.4

22.5

232

-62

ICPC

Administrative procedure

2.4

22.4

159

681

ZX100

NOMESCO Finland

Oral

3.1

22.4

313

K22.7

ICD-10 Finland

Barrett oesophagus

3.3

22.4

267

TK810

NOMESCO Finland

Hemofiltration

4.8

22.4

105

N01

ICPC

Headache

1.7

22.4

421

2538

C09CA06

ATC

candesartan; oral

1.4

22.3

1294

9897

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.1

22.2

294

V03AE02

ATC

sevelamer; oral

5.6

22.2

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

4.8

22.2

102

V03AE01

ATC

polystyrene sulfonate; oral

3.2

22.2

269

S04

ICPC

Lump/swelling localized

1.6

22.1

518

3302

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

22.1

116

430

N02BF01

ATC

gabapentin; oral

1.7

22.1

411

2469

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

4.2

22.1

143

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

22.0

729

5026

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

3.7

22.0

188

R01AD08

ATC

fluticasone; nasal

1.4

22.0

1391

10787

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

21.9

283

1524

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.8

21.9

337

1917

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

4.0

21.9

157

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

3.7

21.9

184

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

21.9

1946

15875

56419

ICD-8 Finland

Functional disorders of intestines, Colon irritabile aliud sive NUD

+∞

21.9

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.7

21.9

118

444

N05CD07

ATC

temazepam; oral

1.5

21.8

639

4290

JHD10

NOMESCO Finland

Myotomy of anal sphincter

62.7

21.8

J45

ICD-10 Finland

Asthma

1.6

21.8

498

3156

XKD00

NOMESCO Finland

Uroflowmetry

1.4

21.8

918

6637

R5599

NOMESCO Finland

Other rehabilitation service

2.3

21.7

159

691

ZXA10

NOMESCO Finland

Bilateral

1.4

21.7

1005

7391

Z01.7

ICD-10 Finland

Laboratory examination

1.5

21.7

731

5058

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

21.7

2021

16593

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

7.7

21.7

K96

ICPC

Haemorrhoids

2.6

21.6

126

493

Z01.2

ICD-10 Finland

Dental examination

1.3

21.6

2274

18979

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

4.0

21.6

150

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.5

21.4

K65.8

ICD-10 Finland

Other peritonitis

8.3

21.4

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

8.3

21.4

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

21.3

236

1207

A03

ICPC

Fever

1.5

21.3

732

5085

Z94.4

ICD-10 Finland

Liver transplant status

6.6

21.3

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

21.2

2424

20437

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

21.2

808

5728

L86

ICPC

Back syndrome with radiating pain

1.8

21.2

309

1730

JFA42

NOMESCO Finland

Endoscopic injection in colon

7.0

21.2

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

21.1

124

487

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

21.1

406

2462

G04BD08

ATC

solifenacin; oral

1.8

21.1

349

2030

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

21.0

552

3615

L12

ICPC

Hand/finger symptom/complaint

1.5

21.0

790

5586

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

21.0

508

3264

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.7

21.0

110

408

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

4.7

21.0

103

56510

ICD-8 Finland

Anal fissure and fistula, Anal fistula

+∞

20.8

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.2

20.8

259

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.5

20.8

205

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.3

20.8

157

692

D07AC01

ATC

betamethasone; topical

1.3

20.7

1935

15865

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

20.7

294

1633

R13

ICD-10 Finland

Dysphagia

1.7

20.7

351

2056

Z53.8

ICD-10 Finland

Procedure not carried out for other reasons

6.2

20.6

K60.4

ICD-10 Finland

Rectal fistula

210.6

20.6

JFG29

NOMESCO Finland

Closure of terminal enterostomy with anastomosis to rectum

210.6

20.6

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

20.5

659

4511

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.0

20.5

303

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

20.5

299

1674

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

20.5

288

1594

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

20.4

439

2739

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

20.4

390

2360

256, ,

Kela drug reimbursment

25.5

20.4

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.1

20.4

278

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

20.3

514

3338

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.5

20.3

110

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.3

20.3

233

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

20.2

177

829

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

20.2

1579

12617

N19

ICD-10 Finland

Unspecified kidney failure

2.0

20.2

205

1017

B37.7

ICD-10 Finland

Candidal sepsis

8.4

20.1

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

20.1

988

7335

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

20.0

390

2372

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.5

20.0

191

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

20.0

165

755

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.0

20.0

141

J01XX08

ATC

linezolid; systemic

4.2

19.9

124

R03AC12

ATC

salmeterol; inhalant

1.9

19.9

244

1292

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

7.0

19.9

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

19.8

251

1344

J01DA06

ATC

[U] cefuroxime

1.5

19.8

718

5037

56905

ICD-8 Finland

Other diseases of intestines and peritoneum, Fistula faecalis

+∞

19.8

5699X

ICD-9 Finland

Other disorders of intestine, Unspecified disorder of intestine

+∞

19.8

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

19.8

260

1409

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

19.8

252

1352

L05

ICPC

Flank/axilla symptom/complaint

1.8

19.7

300

1701

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

19.7

222

1142

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

73.7

19.7

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

19.6

313

1800

R05

ICPC

Cough

1.4

19.6

1198

9217

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.7

19.6

105

394

R55

ICD-10 Finland

Syncope and collapse

1.5

19.6

594

4016

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

2744

13841

2.70

316.85

6.2

4.1

—

(3044640) Blood type and Crossmatch panel - Blood

2955

15544

2.66

312.27

3.5

2.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3892

21893

2.94

307.65

8.9

4.5

34.00

35.27

g/l

29.89

3738

20185

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1762

6919

3.12

307.65

3.4

2.4

2.33

2.29

g/l

2.01

1667

6396

(3022145) Colonoscopy Study observation

2273

3888

8.46

307.65

1.5

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2865

14414

2.77

307.65

3.7

2.4

59.09

60.32

u/l

0.32

2717

13227

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1091

2940

4.26

307.65

1.9

1.6

—

(40768797) Stomach Pathology biopsy report

1641

5922

3.37

307.65

1.4

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2513

11745

2.86

307.65

3.1

2.0

3.06

2.94

mg/l

1.17

2222

9944

(3022948) Iron [Moles/volume] in Serum or Plasma

1854

7510

3.06

307.65

3.4

2.4

11.24

13.20

umol/l

25.34

1757

6980

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1696

6507

3.18

307.65

3.5

2.4

19.82

23.20

16.86

1485

5521

(3048689) Calprotectin [Mass/mass] in Stool

1382

3885

4.25

307.65

3.0

2.1

187.81

136.73

ug/g

3.60

1176

3067

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4384

25806

3.16

307.65

9.0

6.2

11.35

11.94

umol/l

2.36

4239

24478

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3368

19261

2.56

293.58

4.2

2.6

140.51

154.55

ug/l

1.04

3157

17645

(3042936) Bacteria identified in Isolate by Culture

1686

6901

2.95

286.44

2.8

1.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1204

4113

3.37

278.53

3.1

2.3

39.96

53.42

u/l

0.57

1066

3502

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1395

5211

3.14

277.92

4.7

4.1

16.17

27.71

ug/l

1.19

1131

4295

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2373

11777

2.60

274.86

3.5

2.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4366

28750

2.59

273.46

12.3

8.8

4.40

4.15

e9/l

9.07

3819

24866

(3022096) Basophils/100 leukocytes in Blood

3661

22428

2.45

265.31

8.2

5.8

0.65

0.67

2.21

3483

20809

(3006504) Eosinophils/100 leukocytes in Blood

3737

23154

2.45

263.31

8.2

5.8

2.72

2.89

4.40

3550

21529

(3019069) Monocytes/100 leukocytes in Blood

3749

23283

2.45

262.44

8.5

6.1

8.77

8.74

0.28

3562

21692

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5388

39788

3.09

261.65

12.3

7.1

83.85

79.43

u/l

7.42

5216

37261

(3033658) Prothrombin time (PT) actual/Normal

2494

12933

2.51

260.28

6.5

3.7

87.70

88.78

1.25

2450

12615

(3002030) Lymphocytes/100 leukocytes in Blood

3802

23875

2.43

257.87

8.3

5.9

25.35

27.28

22.64

3619

22281

(3018010) Neutrophils/100 leukocytes in Blood

3751

23512

2.41

253.98

8.0

5.7

59.42

57.60

16.81

3569

21908

(3022217) INR in Platelet poor plasma by Coagulation assay

3872

24846

2.39

245.00

19.2

15.5

1.31

1.30

inr

0.23

1261

7073

(40760892) CBC W Ordered Manual Differential panel - Blood

3661

23140

2.34

236.84

8.6

6.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3683

23465

2.32

232.02

3.8

2.4

—

(3002582) Erythrocytes [#/volume] in Urine

2731

15366

2.34

230.72

4.3

3.1

61.31

85.61

e6/l

0.93

2140

11633

(3006315) Basophils [#/volume] in Blood

3819

24767

2.32

229.75

8.0

5.5

0.04

e9/l

0.38

3307

21135

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1326

5315

2.88

228.85

3.8

2.7

6.86

9.48

umol/l

4.87

1181

4635

(3001604) Monocytes [#/volume] in Blood

3803

24702

2.30

226.74

8.0

5.5

0.63

0.60

e9/l

5.58

3293

21095

(3013115) Eosinophils [#/volume] in Blood

3894

25602

2.30

224.67

8.4

5.7

0.19

0.20

e9/l

1.49

3428

22209

(3019198) Lymphocytes [#/volume] in Blood

3874

25416

2.30

224.66

8.1

5.6

1.78

1.92

e9/l

6.87

3422

22210

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1184

4580

2.94

217.26

3.2

2.1

0.21

g/l

0.34

1113

4254

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3897

25937

2.26

213.87

11.3

6.4

1.20

1.21

mmol/l

10.48

3402

21858

(3007164) IgA [Mass/volume] in Serum or Plasma

1660

7740

2.54

210.16

1.6

1.4

2.63

2.56

g/l

0.65

963

4714

(3013826) Glucose [Moles/volume] in Serum or Plasma

4344

30393

2.30

208.76

8.5

4.5

6.87

6.84

mmol/l

0.45

4197

28485

(3018095) Leukocytes [#/volume] in Urine

2957

17733

2.23

208.48

5.0

3.5

108.80

102.78

e6/l

0.13

2219

12455

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2710

15772

2.23

204.83

4.5

3.2

37.34

35.61

u/l

0.18

2589

14878

(3020779) Urea [Moles/volume] in Serum or Plasma

1160

4575

2.87

204.43

10.2

6.8

10.31

10.03

mmol/l

0.60

1115

4355

(3027945) Reticulocytes/100 erythrocytes in Blood

1331

5645

2.71

203.97

2.5

1.83

1.76

1.48

1204

5003

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1731

8355

2.46

202.38

5.3

3.3

0.80

0.82

mmol/l

3.40

1653

7800

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1459

6517

2.60

201.05

9.4

5.5

1.06

1.03

mmol/l

4.01

1396

6038

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1949

9950

2.37

200.65

4.9

3.6

410.93

545.93

ng/l

0.52

1580

8125

(3000991) Gas panel - Venous blood

1074

4163

2.89

194.80

13.5

8.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3307

21170

2.15

192.60

2.4

1.9

90.67

94.94

pmol/l

6.23

1882

10877

(3030467) Casts [#/volume] in Urine by Automated count

2452

14078

2.19

187.77

4.1

3.0

0.51

0.46

e6/l

0.27

1873

10578

(3000570) Elastase.pancreatic [Mass/mass] in Stool

453

1036

4.63

182.80

1.5

1.4

253.73

270.81

ug/g

0.89

308

630

(40768804) Tissue Pathology biopsy report

3169

20266

2.10

181.43

2.6

2.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4499

33036

2.18

175.80

6.1

4.1

1171.33

1538.06

e6/l

0.29

526

(36304419) Bacteria [Presence] in Urine

2358

13635

2.15

174.41

4.1

2.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3505

23539

2.06

172.69

10.7

5.7

1.20

1.21

mmol/l

9.17

3287

21382

(3037467) Urinalysis macro (dipstick) panel - Urine

4637

34665

2.18

169.90

5.8

4.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1589

7925

2.33

168.36

3.6

2.8

2.95

2.17

e6/l

2.22

863

4263

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1622

8162

2.32

168.30

2.1

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1046

4309

2.70

167.09

11.3

7.1

1.35

1.37

mmol/l

0.13

1026

4180

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1695

8761

2.27

164.47

1.3

1.2

2.00

2.18

u/ml

0.21

359

2351

(3023520) Reticulocytes [#/volume] in Blood

1035

4292

2.68

162.89

2.5

2.6

69.74

69.15

e9/l

0.18

743

3257

(3021960) Folate [Moles/volume] in Serum or Plasma

2082

11736

2.14

162.14

1.8

1.5

21.06

20.10

nmol/l

2.00

1873

9982

(3013707) Erythrocyte sedimentation rate by Westergren method

4877

37600

2.20

158.98

5.7

3.8

15.08

12.76

mm/h

17.59

4583

34536

(3018418) pH of Serum or Plasma

2481

15401

1.99

144.77

6.1

3.9

7.40

0.70

434

2994

(3000850) Epithelial cells [#/volume] in Urine

1879

10557

2.10

144.63

3.4

2.5

4.92

5.25

e6/l

0.66

1713

9408

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1607

8568

2.16

141.36

3.4

2.7

1.09

1.42

e6/l

0.47

881

4878

(3012544) pH of Venous blood

1059

4763

2.46

139.11

6.7

3.7

7.36

7.39

0.71

(3002032) Base excess in Venous blood by calculation

1022

4551

2.48

137.04

6.7

3.7

1.70

1.98

mmol/l

1.50

873

3804

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1023

4589

2.46

134.85

6.7

3.7

5.79

5.84

kpa

0.72

989

4449

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

735

2831

2.80

132.05

14.9

9.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2992

20219

1.89

131.81

2.9

2.1

76.58

78.23

nmol/l

2.44

2743

17984

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

636

2270

3.00

131.43

7.0

3.9

24.04

24.18

mmol/l

0.50

628

2217

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

619

2184

3.03

130.52

1.7

1.6

1.63

1.56

g/l

0.89

538

1853

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1201

5858

2.29

130.44

3.9

4.4

233.05

249.10

u/l

4.02

1142

5556

(3003396) Base excess in Arterial blood by calculation

1219

6003

2.27

129.29

12.3

7.2

0.79

1.15

mmol/l

2.36

1016

4763

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

752

2987

2.72

127.09

11.7

7.3

24.82

24.76

mmol/l

0.15

746

2963

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

704

2727

2.77

124.82

13.7

9.3

24.19

24.33

mmol/l

0.59

685

2632

(3027801) Oxygen [Partial pressure] in Arterial blood

1210

6027

2.24

124.39

12.3

7.2

12.62

12.27

kpa

1.57

1165

5723

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1210

6029

2.24

124.28

12.3

7.2

5.09

5.11

kpa

0.40

1163

5726

(3016502) Oxygen saturation in Arterial blood

1114

5367

2.30

124.04

13.0

7.6

95.98

95.59

1.34

1081

5149

(40758558) Short blood count panel - Blood

2064

12548

1.95

123.66

9.1

6.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

531

1782

3.16

121.85

4.0

3.5

351.08

2776.88

u/ml

0.97

452

1541

(3026008) Bacteria identified in Urine by Culture

2374

15190

1.89

121.18

3.9

2.9

—

(3026782) Osmolality of Urine

1728

10011

1.99

118.25

3.6

2.8

539.56

551.90

mosm/kgh2o

1.20

1518

8546

(3007853) Bacteria identified in Skin by Aerobe culture

1136

5619

2.24

118.25

2.1

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4196

32200

1.86

117.32

4.6

2.9

64.09

51.65

u/l

9.95

3969

29614

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1032

4926

2.30

116.91

13.8

8.0

115.70

121.91

g/l

17.79

1014

4776

(3015377) Calcium [Moles/volume] in Serum or Plasma

2602

17293

1.84

116.56

4.6

3.5

2.34

2.36

mmol/l

5.87

2383

15168

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

515

1762

3.09

114.15

3.6

2.9

0.31

0.35

u/ml

1.83

276

1020

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1763

10452

1.94

111.78

2.1

1.7

1.44

1.29

mg/l

0.94

1388

8031

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

406

1220

3.48

111.24

1.4

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1446

8116

2.01

106.78

2.6

2.0

30.70

29.88

4.92

1415

7881

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

600

2335

2.73

104.76

2.6

2.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5887

51582

2.53

104.46

29.4

13.2

31.90

24.82

mg/l

38.61

5227

40359

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

268

641

4.32

101.48

8.2

6.1

12.45

11.59

mg/l

2.00

249

587

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1094

5639

2.13

101.28

1.9

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2338

15541

1.79

100.86

3.5

2.9

1905.71

1463.27

ng/l

2.79

2048

13398

(3003327) Ova and parasites identified in Stool by Light microscopy

365

1092

3.48

100.54

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

935

4545

2.24

100.28

3.4

2.8

224.90

202.67

ng/l

0.80

862

4150

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1599

9479

1.91

99.61

4.1

3.1

2.47

2.46

mmol/l

1.65

1429

8292

(3005719) IgG [Mass/volume] in Serum or Plasma

766

3478

2.36

96.30

3.1

2.7

10.59

10.57

g/l

0.05

707

3166

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1076

5654

2.08

94.08

2.0

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1593

9614

1.87

92.93

1.9

1.7

1101.14

1179.80

nmol/l

2.91

1266

7244

(3028026) IgM [Mass/volume] in Serum or Plasma

635

2709

2.49

91.44

2.0

1.8

1.29

1.43

g/l

0.84

593

2442

(3026493) Urate [Moles/volume] in Serum or Plasma

2106

13916

1.76

90.45

3.4

2.6

4395.98

5057.41

umol/l

0.30

1876

12100

(3024928) Oxygen saturation in Venous blood

322

971

3.44

87.48

4.9

3.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

711

3266

2.32

86.58

14.5

9.0

1.29

1.35

1.24

706

3244

(3025941) Bacteria identified in Stool by Culture

534

2154

2.61

86.30

1.4

1.2

—

(3002256) Pathology report gross observation

1176

6625

1.95

83.60

1.4

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

650

2917

2.36

83.39

1.8

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

762

3675

2.22

82.36

5.9

3.7

113.75

91.37

ng/l

3.22

676

3121

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2306

15955

1.69

81.92

2.4

2.1

214.93

226.31

u/l

0.24

2188

14875

(3021589) Normoblasts [#/volume] in Blood

3049

22743

1.64

80.38

15.7

9.1

0.00

e9/l

0.51

2463

18521

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

381

1344

2.95

79.47

3.2

2.6

3.75

3.60

g/l

1.03

369

1282

(36660697) Celiac disease serology panel - Serum

675

3157

2.27

78.43

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

406

1499

2.82

77.85

2.2

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

1097

6179

1.93

77.46

1.5

1.3

521.59

524.74

titre

0.02

252

1326

(3017143) Hepatitis C virus Ab [Presence] in Serum

868

4505

2.07

77.34

1.9

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

466

1861

2.62

76.63

2.2

1.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

751

3715

2.16

75.84

5.4

3.1

4.98

4.54

kpa

4.39

725

3582

(3052851) Hemolysis interference index of Serum or Plasma

392

1448

2.82

75.05

3.7

3.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

279

859

3.35

73.24

1.5

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

488

2042

2.50

72.74

2.3

1.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1052

5964

1.91

72.42

2.0

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

355

1270

2.90

72.09

3.0

2.6

205.00

194.52

1.21

340

1216

(3036481) Cortisol [Moles/volume] in Serum or Plasma

792

4097

2.06

70.83

2.6

2.4

369.94

379.93

nmol/l

0.51

741

3772

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

196

489

4.10

70.09

1.5

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

460

1937

2.48

67.53

2.3

2.2

3.67

3.74

g/l

0.40

428

1740

(3000494) Fungus identified in Specimen by Culture

1003

5721

1.89

67.36

1.8

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

460

1941

2.47

67.23

2.4

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

460

1942

2.47

67.15

2.4

2.2

7.45

7.40

g/l

0.22

427

1744

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

196

505

3.97

67.06

1.5

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

811

4311

2.01

67.06

2.5

65.01

66.35

g/l

4.91

765

3902

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

919

5108

1.93

66.72

1.9

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

337

1225

2.85

66.39

1.3

1.2

109.31

189.30

titre

0.56

100

(4035726) Immunohistochemistry procedure

877

4808

1.95

66.29

1.5

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

336

1224

2.84

65.92

1.3

1.2

515.00

924.78

titre

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

439

1830

2.50

65.83

2.4

2.2

3.00

2.96

g/l

0.29

407

1634

(3019550) Sodium [Moles/volume] in Serum or Plasma

5982

54617

2.23

65.59

33.1

15.6

139.34

139.76

mmol/l

30.89

5904

53147

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

370

1423

2.70

65.43

2.8

2.2

87.13

90.96

2.00

359

1365

(3023103) Potassium [Moles/volume] in Serum or Plasma

5988

54770

2.22

64.07

33.5

15.7

3.96

3.98

mmol/l

8.76

5907

53188

(3024522) Salmonella sp identified in Specimen by Organism specific culture

190

495

3.92

64.01

1.5

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

373

1457

2.66

63.94

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

688

3546

2.05

61.72

2.3

—

(3036489) Thrombin time

418

1760

2.47

61.27

2.5

2.0

21.77

21.44

0.53

385

1545

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

185

493

3.83

60.37

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

185

493

3.83

60.37

1.5

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5529

49439

1.80

60.09

26.7

12.9

77.87

78.41

ml/min/173m2

1.00

4849

40644

(3025468) Yersinia sp identified in Specimen by Organism specific culture

184

492

3.82

59.76

1.5

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

423

1818

2.42

59.24

2.3

2.2

9.90

10.16

g/l

0.58

387

1604

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

633

3210

2.08

59.23

5.1

3.6

5.08

5.16

kpa

1.37

610

3050

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3470

27878

1.53

58.70

2.9

2.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

341

1338

2.63

57.86

1.4

2.67

21.52

iu/ml

—

(3009343) pH of Capillary blood

623

3170

2.07

57.71

5.0

3.6

7.41

7.42

0.85

104

413

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5320

47230

1.70

57.08

5.5

4.5

1.92

2.19

mu/l

2.28

4945

42751

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

314

1190

2.72

57.06

1.5

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

819

4621

1.88

56.16

2.8

2.2

7.79

8.34

ug/l

0.27

748

4054

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

264

921

2.95

56.01

8.1

5.6

414.25

2073.75

iu/ml

0.52

139

(3028626) Oxygen [Partial pressure] in Capillary blood

304

1146

2.73

55.81

4.8

3.2

8.34

8.05

kpa

1.14

295

1123

(3014765) Yersinia sp identified in Stool by Organism specific culture

293

1090

2.77

55.18

1.4

1.1

—

(3000492) Spirometry study

820

4672

1.86

54.43

1.6

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

329

1307

2.60

54.41

3.5

3.1

24.29

24.85

mmol/l

1.36

324

1284

(42529406) Shigella sp [Presence] in Stool by Culture

292

1094

2.75

54.24

1.4

1.1

—

(3044889) 12 lead EKG panel

4428

37831

1.54

53.60

4.5

3.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

288

1082

2.74

53.21

1.3

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

459

2141

2.23

53.03

1.4

1.6

3.20

18.84

u/ml

2.94

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4456

38298

1.52

50.86

4.5

3.8

14.73

14.90

pmol/l

4.39

4116

34511

(3023183) Ammonium ion [Moles/volume] in Plasma

275

1040

2.72

50.15

4.5

2.5

35.23

33.75

umol/l

0.50

255

934

(3003694) ABO and Rh group [Type] in Blood

1888

13654

1.54

49.94

1.4

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

523

2630

2.08

49.77

3.3

2.7

0.41

0.31

e6/l

0.72

517

2567

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

583

3062

1.99

49.17

5.1

3.5

1.96

1.93

mmol/l

0.05

437

2262

(3047181) Lactate [Moles/volume] in Blood

372

1649

2.33

48.44

10.5

5.8

1.34

mmol/l

0.00

335

1451

(3034860) Kappa light chains.free [Mass/volume] in Serum

370

1639

2.33

48.25

2.7

3.3

194.76

56.43

mg/l

0.52

302

1332

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

368

1637

2.32

47.52

2.7

3.3

43.19

41.30

mg/l

0.13

301

1329

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

343

1483

2.39

47.26

2.5

2.1

0.05

0.02

g/l

0.38

320

1344

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

373

1682

2.29

46.64

2.6

2.3

0.85

0.93

g/l

0.18

333

1429

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2542

19759

1.47

46.55

4.6

3.4

51.44

78.33

ng/l

0.59

1884

14161

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

316

1326

2.45

46.51

1.7

1.5

0.15

3.26

iu/ml

0.82

298

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

358

1591

2.32

46.32

2.7

3.2

2.42

3.03

ratio

0.18

139

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

432

2077

2.16

46.16

2.6

1.9

3.13

2.28

ug/l

0.47

386

1824

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5990

55768

1.97

45.79

17.1

10.0

26.74

26.51

u/l

0.29

5887

53459

(3009508) Creatinine [Moles/volume] in Urine

2262

17256

1.48

45.21

3.8

3.1

7.32

7.59

mmol/l

2.15

1951

14427

(3009261) Glucose [Presence] in Urine by Test strip

3064

24777

1.45

45.12

4.4

3.5

0.00

estimate

0.05

603

4400

(3012516) Albumin [Mass/volume] in Urine

2193

16649

1.48

44.82

3.8

3.2

411.25

342.76

mg/l

0.31

1580

10622

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

317

1356

2.41

44.72

2.5

2.2

0.00

g/l

-0.00

296

1243

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

380

1758

2.23

44.67

2.9

2.3

495.28

694.37

ug/l

0.76

364

1661

(3004119) Hemoglobin [Mass/volume] in Venous blood

562

3010

1.95

44.65

5.5

3.4

121.30

129.41

g/l

11.20

546

2943

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

321

1383

2.39

44.56

2.5

2.1

0.00

g/l

0.50

298

1247

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

895

5563

1.71

43.51

4.8

3.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

555

2998

1.93

42.94

1.6

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

341

1536

2.29

42.72

2.4

2.1

36.53

37.67

g/l

2.43

309

1337

(3021601) Nitrite [Presence] in Urine by Test strip

3019

24513

1.43

42.53

6.0

4.6

0.00

estimate

0.32

624

4559

(3020682) Albumin/Creatinine [Ratio] in Urine

2268

17529

1.45

41.41

4.5

3.8

12.99

8.66

mg/mmol

3.91

1584

11084

(3015736) pH of Urine

2485

19536

1.44

41.41

3.8

3.2

5.71

5.82

0.89

141

1246

(3017181) Myelocytes/100 leukocytes in Blood

721

4276

1.77

41.30

4.1

4.0

0.93

0.97

0.19

333

1461

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

218

809

2.75

41.23

1.3

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

207

753

2.81

40.66

1.4

1.3

267.56

279.23

u/ml

0.20

133

462

(3049717) Cytology report of Urine Cyto stain

408

2016

2.09

40.52

2.7

2.8

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

219

4.53

40.50

2.9

2.4

101.67

96.28

0.61

211

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

224

856

2.67

40.02

1.6

1.5

—

(3019060) Gas panel - Arterial blood

614

3503

1.83

39.98

8.5

4.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

667

3916

1.78

39.46

3.9

0.57

0.72

1.08

304

1264

(3021901) Oxygen saturation in Capillary blood

241

962

2.56

39.42

3.4

2.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

260

1079

2.47

39.18

1.6

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

205

757

2.76

39.15

1.3

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

112

285

3.98

39.06

1.3

1.2

109.07

81.34

u/l

0.97

244

(3035350) Ketones [Presence] in Urine by Test strip

2994

24515

1.41

38.94

4.4

3.5

0.00

estimate

0.12

654

4883

(3042733) HLA Ab [Presence] in Serum

131

5.62

38.82

5.5

4.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

183

4.80

38.71

37.5

33.0

7.23

7.49

ug/l

0.41

169

(3037756) Immunofixation for Serum or Plasma

261

1093

2.45

38.56

1.5

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

110

279

3.99

38.54

1.3

1.2

36.59

19.65

u/l

1.27

234

(3013139) Helicobacter pylori Ag [Presence] in Stool

522

2869

1.89

38.20

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

194

709

2.79

37.79

1.6

0.75

0.86

g/l

0.59

138

529

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

249

1030

2.47

37.78

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

249

1030

2.47

37.78

1.4

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

195

4.61

37.71

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

506

2765

1.90

37.68

1.6

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

185

663

2.84

37.38

2.8

2.5

689.51

806.46

u/ml

0.06

185

655

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

347

1663

2.15

37.28

1.5

1.6

161.67

315.56

titre

1.22

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

157

516

3.09

37.01

1.3

1.2

82.49

65.59

u/l

0.31

137

456

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

198

4.54

37.01

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

678

4081

1.74

36.67

4.2

4.0

0.10

0.13

0.52

292

1276

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

201

765

2.68

36.21

1.7

1.5

103.62

117.54

u/ml

0.72

160

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

359

1766

2.09

36.03

1.1

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

204

786

2.65

35.87

1.3

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

260

1124

2.37

35.79

1.3

1.2

—

(3013512) EKG study

2008

15491

1.43

35.73

4.4

3.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1577

11630

1.47

35.68

3.8

3.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

215

856

2.56

35.37

1.6

1.4

—

14.41

—

(3022313) Gas panel - Capillary blood

429

2281

1.94

34.62

5.4

3.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

188

708

2.70

34.59

4.1

2.8

409.71

2089.86

u/ml

0.99

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

122

359

3.44

34.45

1.3

1.2

134.78

183.22

titre

0.32

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

827

5337

1.63

34.23

1.8

1.7

1.59

1.50

2.59

707

4631

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

224

927

2.47

33.97

1.5

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

246

1065

2.36

33.76

3.7

3.4

767.66

1225.45

u/ml

0.24

219

980

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

287

1329

2.21

33.60

1.6

1.5

0.24

g/l

0.23

272

1255

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

247

3.93

33.02

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1136

7949

1.52

32.94

1.3

30.99

37.97

iu/ml

1.22

359

2532

(3002385) Erythrocyte distribution width [Ratio]

4937

44661

1.44

32.93

34.3

15.9

16.04

15.20

0.48

4884

43732

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

292

1383

2.16

32.31

1.6

1.5

1.19

g/l

0.11

279

1306

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

200

4.24

32.08

3.1

2.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

270

1244

2.22

32.00

2.6

3.4

—

(3051611) Lipemic interference index of Serum or Plasma

148

517

2.91

31.39

4.4

3.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

6.20

31.27

3.7

3.3

6.74

7.22

mg/l

0.23

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

116

354

3.32

30.97

1.4

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

257

1180

2.23

30.72

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

275

3.64

30.54

2.0

1.7

—

(3037121) Protein [Mass/volume] in Urine

323

1631

2.03

30.17

4.1

3.0

0.33

0.31

g/l

0.12

206

696

(3009542) Hematocrit [Volume Fraction] of Blood

6078

57784

1.83

30.13

42.3

19.7

38.92

40.52

19.98

5753

53576

(3007461) Platelets [#/volume] in Blood

6080

57819

1.82

29.97

41.3

19.6

254.22

246.18

e9/l

14.01

5977

56050

(3024731) MCV [Entitic volume]

6080

57853

1.81

29.42

41.2

19.6

91.40

91.35

0.33

6030

56844

(3000963) Hemoglobin [Mass/volume] in Blood

6081

57869

1.81

29.37

41.6

19.7

129.61

136.02

g/l

166.20

6031

56866

(3026361) Erythrocytes [#/volume] in Blood

6080

57857

1.81

29.36

41.3

19.6

4.34

4.50

e12/l

91.63

5965

55896

(3010813) Leukocytes [#/volume] in Blood

6080

57860

1.81

29.31

41.3

19.6

7.12

6.72

e9/l

30.53

5962

55892

(3035941) MCH [Entitic mass]

6078

57848

1.81

29.11

41.1

19.5

30.22

30.42

13.41

6030

56838

(3003338) MCHC [Mass/volume]

4788

43399

1.39

28.94

36.2

17.3

330.18

332.40

g/l

48.16

4760

43044

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5314

49081

1.46

28.74

7.1

5.8

40.43

40.27

mmol/mol

0.56

5003

45038

(3020961) Endomysium IgA Ab [Titer] in Serum

339

1772

1.96

28.71

1.1

77.78

195.17

titre

—

(3004809) Band form neutrophils/100 leukocytes in Blood

197

831

2.41

28.69

2.9

3.5

1.65

1.40

0.43

181

722

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

159

606

2.66

28.62

1.1

1.56

1.52

g/l

0.52

148

535

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1062

7531

1.49

28.46

1.3

1.2

13.55

14.48

u/ml

0.07

338

2884

(3016650) Hepatitis A virus Ab [Presence] in Serum

182

746

2.48

28.21

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

271

1316

2.11

28.12

5.4

3.3

1.77

1.54

mg/l

3.75

250

1191

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1825

14307

1.38

28.10

1.8

1.6

1.43

1.36

mmol/l

2.85

1573

11820

(3025159) Blasts/100 leukocytes in Blood

614

3866

1.65

27.75

4.2

4.0

0.03

0.41

2.11

232

1069

(3004716) Salmonella sp identified in Stool by Organism specific culture

343

1821

1.93

27.75

1.4

—

(3012501) Base excess in Blood by calculation

243

1139

2.18

27.62

6.1

3.8

2.87

2.60

mmol/l

0.82

179

771

(3013290) Carbon dioxide [Partial pressure] in Blood

243

1140

2.18

27.56

6.1

3.8

5.03

4.99

kpa

0.27

235

1116

(1616796) Gas panel - Central venous blood

242

1134

2.18

27.52

4.6

3.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

448

2605

1.77

27.10

1.4

1.3

315.01

256.83

u/ml

0.22

422

2395

(3027315) Oxygen [Partial pressure] in Blood

243

1148

2.16

27.08

6.1

3.8

8.90

8.57

kpa

1.44

235

1123

(3024891) Influenza virus A+B Ag [Presence] in Specimen

236

1111

2.17

26.54

1.2

1.1

—

(3011648) Oxygen content in Venous blood

110

361

3.08

26.10

3.8

2.4

11.54

10.94

0.71

110

361

(3021162) Amylase [Enzymatic activity/volume] in Specimen

5.29

26.01

2.7

3.2

2205.12

2676.49

u/l

0.12

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

396

2249

1.81

25.92

4.0

3.6

60.41

65.11

u/ml

0.12

381

2165

(3010421) pH of Blood

267

1332

2.05

25.79

6.0

3.8

7.42

0.29

245

1210

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

184

794

2.36

25.50

1.6

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

184

794

2.36

25.50

1.6

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

363

2019

1.85

25.43

2.0

1.9

37.32

38.29

u/l

0.44

317

1750

(3010375) cycloSPORINE [Mass/volume] in Blood

205

3.79

25.32

32.3

25.5

126.87

111.24

ug/l

1.07

171

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

6.94

24.99

10.1

11.3

4.08

5.62

mmol/l

3.78

(3027273) Bicarbonate [Moles/volume] in Venous blood

421

2461

1.76

24.98

5.7

3.4

24.48

25.21

mmol/l

3.45

403

2386

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

175

746

2.38

24.93

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

237

1146

2.11

24.89

1.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

535

3342

1.65

24.87

12.3

7.1

24.42

24.72

mmol/l

0.93

515

3164

(3000012) Reticulocyte production index

177

760

2.37

24.81

1.9

2.2

—

(3019225) pH of Specimen

754

5121

1.53

24.57

5.6

4.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

237

1160

2.08

24.11

1.6

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

151

614

2.49

23.86

1.6

1.5

—

(3003181) Sodium [Moles/volume] in Urine

186

833

2.27

23.66

2.2

1.3

59.43

63.75

mmol/l

0.64

139

684

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5488

51432

1.44

23.44

5.3

4.7

6.12

6.02

mmol/l

6.18

5106

46555

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

101

4.98

23.42

2.7

1.6

8.45

9.51

mg/l

0.68

(3017354) Segmented neutrophils/100 leukocytes in Blood

132

511

2.62

23.10

2.7

3.4

60.81

56.54

1.32

122

422

(3021788) Differential panel - Synovial fluid

193

890

2.20

22.89

1.6

1.5

—

(3024471) HLA-A [Type]

149

4.12

22.62

1.0

—

(3024932) HLA-DR beta [Type]

145

4.17

22.56

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

5.03

22.28

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

201

3.61

22.15

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

201

3.61

22.15

1.3

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

252

1301

1.97

22.14

2.0

1.9

11.71

11.22

mg/l

0.43

241

1206

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

156

670

2.36

21.90

1.3

1.2

7.29

3.01

u/ml

0.47

207

(3023419) Bacteria identified in Sputum by Culture

173

785

2.24

21.36

2.7

2.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

279

3.11

20.89

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

274

3.13

20.87

1.1

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

369

2188

1.73

20.80

10.6

4.9

1.77

1.65

1.03

352

2039

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

275

3.12

20.74

1.1

1.0

—

(3039000) Anion gap in Blood

234

1207

1.97

20.63

14.7

6.6

11.05

11.24

mmol/l

0.37

217

1073

(3018572) Chloride [Moles/volume] in Blood

234

1208

1.97

20.58

14.7

6.6

105.61

105.25

mmol/l

0.53

217

1074

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

272

3.12

20.47

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

181

858

2.14

20.07

1.6

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

297

2.99

19.98

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

361

2154

1.72

19.90

10.9

5.0

0.91

0.89

0.53

343

2010

(3019977) pH of Arterial blood

277

3.06

19.86

3.9

2.6

7.42

7.43

0.30

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

331

2.87

19.79

1.1

1.0

299.29

286.34

mg/l

0.93

296

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

118

472

2.53

19.38

1.1

94.38

96.98

0.47

110

441

(40767503) Oxygen content in Capillary blood by calculation

217

1115

1.98

19.36

3.3

2.5

15.56

16.27

1.41

124

586

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

444

2822

1.62

19.18

3.5

3.3

4.41

4.46

pmol/l

0.39

386

2492

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

310

2.90

19.12

1.9

1.5

4.81

6.29

u/l

0.54

251

(4062490) Immunoglobulin typing, IgG

114

453

2.54

18.99

1.4

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

147

659

2.26

18.74

1.3

1.2

3.64

4.61

u/ml

0.46

277

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

148

666

2.25

18.69

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

113

451

2.53

18.66

1.4

1.3

0.39

0.42

g/l

0.47

308

(3028192) IgG subclass 2 [Mass/volume] in Serum

113

451

2.53

18.66

1.4

1.3

2.88

2.96

g/l

0.16

310

(3051651) Icteric interference index of Serum or Plasma

272

3.00

18.58

5.2

3.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

113

452

2.53

18.57

1.4

1.3

6.80

6.72

g/l

0.06

309

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

172

3.57

18.54

1.1

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

216

3.26

18.51

1.4

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

216

3.26

18.51

1.4

1.8

—

(40761536) Microorganisms panel - Urine sediment

619

4277

1.49

18.38

5.8

3.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

142

633

2.27

18.35

1.1

119.00

116.03

0.42

132

559

(1002224) Polysomnography panel

309

1806

1.75

18.34

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1399

11185

1.32

17.45

1.9

1.7

37799090.76

30610013.17

pmol/l

0.16

1172

9203

(40759836) Histone Ab [Presence] in Serum by Immunoblot

305

2.81

17.33

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

306

2.80

17.23

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

133

594

2.26

17.14

1.4

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

128

564

2.29

17.03

2.7

2.0

17.00

2.07

titre

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

308

1837

1.71

17.02

2.7

2.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

309

2.77

16.93

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

309

2.77

16.93

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

309

2.77

16.93

1.1

—

(40761511) CBC panel - Blood by Automated count

5663

53957

1.39

16.78

25.2

12.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

305

2.78

16.77

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

196

1025

1.94

16.66

1.1

3.58

10.58

u/ml

1.32

117

(44816559) Phosphatidylethanol [Mass/volume] in Blood

155

750

2.09

16.37

1.5

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

872

6552

1.38

16.29

1.5

1.4

—

(3012441) Differential panel - Pleural fluid

133

609

2.21

16.16

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

245

1392

1.79

16.06

1.5

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

143

676

2.14

16.05

1.6

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

124

555

2.26

15.93

1.8

1.5

—

(40768446) Kidney Pathology biopsy report

171

3.35

15.81

1.8

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

139

656

2.14

15.68

1.4

1.3

0.10

0.22

nmol/l

—

(40768441) Liver Pathology biopsy report

363

2.56

15.62

1.6

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

138

656

2.13

15.29

1.4

1.3

0.66

2.37

nmol/l

0.49

132

633

(3014148) Varicella zoster virus Ab [Titer] in Serum

105

447

2.37

15.16

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

217

1213

1.82

15.04

1.6

18559.60

11973.02

e6/l

1.20

157

863

(3006442) Creatine [Moles/volume] in Serum or Plasma

330

2.60

14.94

1.7

1.5

105.59

81.89

umol/l

2.65

330

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

318

1980

1.64

14.94

6.5

3.8

25.14

24.90

mmol/l

0.70

304

1820

(3023420) DNA double strand Ab [Units/volume] in Serum

109

475

2.32

14.93

1.3

27.86

24.37

iu/ml

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

169

876

1.95

14.79

1.4

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

104

447

2.35

14.71

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

113

3.82

14.54

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

184

989

1.89

14.45

1.2

—

243.64

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

112

502

2.25

14.38

1.2

1.1

—

(3022621) pH of Urine by Test strip

472

3252

1.49

14.15

3.2

2.7

—

(3045142) Bone marrow Pathology biopsy report

125

591

2.14

14.08

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

205

1152

1.80

13.98

2.9

2.2

122.76

129.21

g/l

2.63

161

835

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

136

3.47

13.83

1.2

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

129

625

2.09

13.65

1.6

1.4

30773.56

42734.14

e6/l

0.45

360

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

458

3161

1.48

13.61

2.4

2.3

43.72

22.86

au/ml

1.27

213

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5257

49865

1.29

13.59

4.6

4.0

1.40

1.30

mmol/l

17.08

4896

45219

(3009214) Lutropin [Units/volume] in Serum or Plasma

178

971

1.86

13.38

1.3

1.4

11.26

10.89

u/l

0.11

132

785

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

239

2.78

13.33

1.3

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

256

2.71

13.30

1.2

2.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

256

2.71

13.30

1.2

2.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

115

542

2.14

13.09

1.8

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

115

542

2.14

13.09

1.8

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

142

3.33

12.96

1.2

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

289

2.58

12.91

2.6

2.7

483.43

496.62

e6/l

0.09

245

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

12.98

12.88

3.0

3.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

398

2.33

12.88

1.4

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

143

3.30

12.82

1.1

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

160

856

1.89

12.80

1.8

1.9

4.84

4.93

mmol/24h

0.13

138

740

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

444

2.25

12.74

2.4

2.3

—

(3016038) Potassium [Moles/volume] in Urine

291

2.56

12.73

2.3

1.2

35.57

35.51

mmol/l

0.01

248

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

206

1193

1.75

12.72

1.3

5.27

6.96

u/ml

0.33

189

(3023199) Leukocytes [#/volume] in Pleural fluid

136

691

1.99

12.66

1.5

1903.28

2232.00

e6/l

0.27

493

(3044941) Cell count panel - Synovial fluid

144

748

1.95

12.59

1.5

1.4

—

(3044927) Protein electrophoresis panel - Urine

108

505

2.16

12.56

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

203

1177

1.75

12.49

1.3

1.2

2.73

3.25

u/ml

0.33

124

(3003434) Protein [Mass/volume] in Pleural fluid

150

793

1.91

12.45

1.5

1.4

29.53

32.30

g/l

1.51

132

717

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

176

981

1.82

12.38

1.3

1.2

3.77

3.81

u/ml

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

399

2.30

12.37

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1543

12967

1.25

12.30

4.4

3.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

189

2.93

12.25

5.4

5.6

59.45

1284.60

mg/l

0.50

138

(3014051) Protein [Presence] in Urine by Test strip

218

1298

1.70

12.20

2.6

2.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

129

653

2.00

12.16

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

434

2.23

12.14

1.2

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

434

2.23

12.14

1.2

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

434

2.23

12.14

1.2

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

274

1733

1.61

12.12

1.2

0.36

1.26

u/ml

2.08

159

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2341

20600

1.21

11.92

5.2

4.9

2.60

3.23

ug/l

1.57

2127

18449

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5548

53198

1.30

11.78

5.7

5.0

2.57

2.73

mmol/l

30.26

5189

48708

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

167

931

1.81

11.76

1.4

209.47

176.75

pmol/l

0.27

160

910

(3027923) C peptide [Moles/volume] in Serum or Plasma

268

2.55

11.68

1.4

1.3

1.19

1.21

nmol/l

0.05

207

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

410

2860

1.46

11.55

1.3

58.13

50.98

au/ml

0.23

170

(3021387) Prolactin [Units/volume] in Serum or Plasma

182

1047

1.76

11.54

1.7

303.44

306.66

mu/l

0.04

168

962

(40768443) Skin Pathology biopsy report

332

2223

1.52

11.45

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

213

1284

1.68

11.41

1.3

1.2

17.83

32.13

u/ml

0.44

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

278

2.50

11.34

2.6

2.8

0.22

0.23

e9/l

0.11

242

(3000093) Morphology [Interpretation] in Blood Narrative

100

473

2.13

11.33

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5437

52057

1.27

11.28

5.1

4.5

4.45

4.63

mmol/l

30.85

5105

47922

(3026692) Albumin [Mass/volume] in Peritoneal fluid

125

3.29

11.19

1.4

9.91

13.16

g/l

1.79

100

(3011412) CD3 cells [#/volume] in Blood

441

2.15

10.90

2.5

2.4

1.15

1.13

e9/l

0.08

399

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5394

51654

1.26

10.79

5.0

4.5

1.40

1.46

mmol/l

18.41

5064

47266

(3033799) Differential panel - Peritoneal fluid

166

2.91

10.62

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

107

533

2.02

10.60

2.2

2.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

356

2.26

10.56

1.6

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

482

2.07

10.44

1.4

1.8

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

5.14

10.29

2.2

1.9

41.33

70.35

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.65

10.22

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

480

2.06

10.18

3.1

2.7

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

13.11

10.14

1.1

1.2

29.86

41.20

u/ml

—

(4200892) Spirometry reversibility

485

3571

1.39

10.12

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

103

515

2.02

10.12

1.5

1.8

—

(3002619) Bacteria identified in Specimen by Culture

3.45

9.99

1.2

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

513

6789

0.73

9.98

11.5

6.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

277

1840

1.53

9.95

5.9

4.3

1.48

1.39

mmol/l

0.74

271

1808

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1898

16597

1.20

9.87

4.3

21.64

22.03

0.48

905

8420

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

329

2.26

9.82

2.3

2.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

420

2.11

9.81

1.2

—

(4281824) Cell count and differential, peritoneal fluid

105

535

1.98

9.80

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

436

2.08

9.65

2.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

13.36

9.65

1.1

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

111

581

1.93

9.59

1.4

1.2

—

(3045414) Leukocytes [Presence] in Urine

321

2216

1.47

9.58

1.9

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

106

547

1.95

9.55

3.2

4.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

10.02

9.50

1.1

1.2

—

(3017732) Neutrophils [#/volume] in Blood

462

3416

1.38

9.41

3.4

3.0

4.81

4.77

e9/l

0.05

365

2701

(3034274) Bile acid [Moles/volume] in Serum --fasting

230

2.49

9.40

2.4

2.0

21.61

15.61

umol/l

0.29

159

(3023487) Leukocytes [#/volume] in Peritoneal fluid

184

2.68

9.35

1.6

1.9

1537.14

5057.91

e6/l

0.38

125

(3011335) Digoxin [Mass/volume] in Serum or Plasma

4.68

9.28

2.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

153

895

1.73

9.23

1.7

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

174

2.71

9.22

1.7

1.8

25742.86

94654.26

u/ml

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

163

2.77

9.20

1.6

1.7

12488.47

19356.50

e6/l

0.20

(40768806) Pleura Pathology biopsy report

116

626

1.87

9.16

1.5

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

175

1069

1.65

9.00

2.8

3.0

0.78

0.82

nmol/l

0.43

127

832

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

109

583

1.88

8.86

1.4

1.3

—

nmol/l

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

392

2853

1.40

8.79

1.2

175.15

139.73

iu/ml

0.72

116

1061

(21494434) Karyotype in Bone marrow

432

2.03

8.77

1.1

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.78

8.76

6.8

5.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

204

1303

1.58

8.76

1.2

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

136

783

1.75

8.70

1.6

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

125

703

1.79

8.66

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

120

667

1.81

8.65

2.3

2.0

1689.81

3588.32

u/l

0.75

265

(3011985) Renin [Units/volume] in Plasma

118

654

1.82

8.59

1.4

66.95

64.30

mu/l

0.06

109

586

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

165

1008

1.65

8.51

2.6

1.8

0.90

0.81

nmol/l

0.95

148

851

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

487

1.94

8.42

1.2

—

45.20

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

501

1.93

8.42

1.1

2.48

3.64

u/ml

0.70

234

(3023323) Follitropin [Units/volume] in Serum or Plasma

216

1412

1.55

8.40

1.4

1.3

30.87

33.69

iu/l

0.65

174

1211

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.24

8.32

1.0

1.3

288.18

335.80

pmol/l

0.34

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

125

712

1.77

8.32

1.6

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

208

2.46

8.27

2.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

302

2.20

8.24

1.4

1.3

2.36

1.67

u/ml

0.17

175

(3047189) Immunofixation for 24 hour Urine

258

2.30

8.21

1.9

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

397

2.03

8.11

1.6

1.5

—

(3004451) EKG impression Narrative

260

2.28

8.07

1.3

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1384

11939

1.20

8.07

3.2

3.0

0.77

0.79

ug/l

0.31

1018

8120

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

182

1156

1.59

8.04

1.4

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

109

3.04

7.98

1.2

1.3

22.97

24.77

g/l

0.28

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

380

2.04

7.94

1.3

1.2

76.20

56.94

u/ml

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

154

2.67

7.87

4.9

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

154

2.67

7.87

4.9

2.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

178

2.54

7.80

1.8

2.0

166.00

131.16

umol/l

0.18

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

383

2.02

7.78

1.3

1.2

64.00

36.67

u/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

497

1.88

7.64

3.9

3.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

316

2272

1.41

7.64

6.2

3.9

46.42

48.09

0.56

311

2238

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

254

2.25

7.62

3.1

2.9

37.27

38.05

0.09

135

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

120

698

1.73

7.47

1.6

1.4

—

(3036180) Methadone [Presence] in Urine

119

2.87

7.46

1.8

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

119

2.87

7.46

1.2

1.1

—

(3017704) Immunofixation for Urine

302

2.13

7.44

1.3

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

208

1389

1.51

7.38

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

104

2.99

7.33

2.6

2.2

202.00

350.00

e6/l

0.31

(3020876) Protein [Mass/time] in 24 hour Urine

105

592

1.79

7.29

2.2

2.5

1.40

1.39

g/24h

0.01

299

(3011288) Drugs identified in Urine by Screen method

105

594

1.78

7.21

2.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

116

2.85

7.19

2.8

1.5

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

204

2.36

7.17

2.9

2.7

39319.27

41848.76

ug/l

0.53

204

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

107

610

1.77

7.16

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

503

1.84

7.07

1.6

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

4.05

7.07

1.2

1.1

122.50

126.36

ug/l

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

565

4486

1.28

7.05

6.3

3.7

1.22

1.23

mmol/l

1.27

506

3870

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

163

1043

1.58

7.03

1.3

1.4

33.17

23.06

e6/l

0.20

130

800

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

108

621

1.75

7.03

1.8

1.5

61.67

60.53

0.10

373

(3023511) Choriogonadotropin [Units/volume] in Urine

310

2.07

6.98

1.4

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

163

1045

1.57

6.98

1.4

1.5

709.67

1241.54

e6/l

0.52

132

857

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.69

6.90

1.1

1.3

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

7.51

6.88

1.5

1.4

0.59

1.44

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

7.51

6.88

1.5

1.4

1.35

3.90

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

7.51

6.88

1.5

1.4

1.36

2.83

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

7.51

6.88

1.5

1.4

1.69

3.98

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

7.51

6.88

1.5

1.4

2.36

3.82

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

7.51

6.88

1.5

1.4

0.88

2.93

mg/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

209

1420

1.49

6.86

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

137

2.64

6.78

1.8

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

341

2.00

6.77

2.7

2.4

—

(3020891) Body temperature

287

2082

1.40

6.63

7.5

4.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

106

624

1.71

6.39

1.2

1.4

283.09

465.80

pmol/l

0.57

527

(3042631) Mycobacterium sp identified in Specimen

122

747

1.65

6.34

2.9

2.8

—

(3028707) Methadone [Presence] in Urine by Screen method

407

1.88

6.28

3.2

2.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.45

6.27

2.1

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

145

929

1.57

6.27

1.2

58.18

43.81

u/ml

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

147

945

1.57

6.26

4.5

3.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

490

3882

1.28

6.23

2.4

2.1

12.11

12.72

nmol/l

0.87

435

3464

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

5.32

6.14

2.4

1.6

26.29

8.35

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

382

1.89

6.13

2.2

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

272

2.07

6.12

3.9

4.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.66

6.11

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

530

1.75

6.01

1.6

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

392

1.87

6.00

1.6

1.3

0.99

1.29

promille

1.13

301

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.01

5.98

1.1

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

129

2.57

5.94

1.1

—

(3048879) Bone marrow aspiration report

159

2.40

5.93

1.2

2.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

118

2.63

5.88

1.3

1.1

92.40

85.96

0.37

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.90

5.87

2.2

1.7

185.81

124.33

ng/l

0.84

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

567

1.70

5.76

2.5

2.1

18.77

27.27

mg/l

0.91

155

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

286

2.00

5.73

1.6

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

104

629

1.66

5.71

1.1

5.48

12.05

au/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

166

1120

1.49

5.70

2.0

1.7

5.38

4.77

iu/l

0.20

393

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

164

1106

1.50

5.65

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

115

2.62

5.62

1.2

98.57

84.53

0.77

(3000330) Specific gravity of Urine by Test strip

337

2577

1.32

5.60

3.6

3.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

114

713

1.61

5.50

1.8

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

210

2.15

5.48

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

370

1.85

5.40

1.5

24.43

23.84

u/ml

0.05

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

173

1192

1.46

5.38

1.3

699.85

540.81

mg/l

0.50

165

1130

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

181

1263

1.45

5.27

2.2

1.7

—

(3008295) Osmolality of Serum or Plasma

485

1.72

5.21

1.4

277.21

280.18

mosm/kgh2o

0.51

384

(3008402) Methanol [Moles/volume] in Serum or Plasma

3.64

5.19

1.4

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

132

2.43

5.19

1.3

1.5

93.88

243.15

nmol/24h

0.94

132

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

523

4275

1.24

5.14

3.3

2.6

64.57

64.12

ml/min/173m2

0.10

254

1664

(1001926) Buprenorphine [Presence] in Urine by Screen method

113

718

1.58

5.14

2.6

1.8

—

(3006462) Nitrate [Presence] in Urine

223

2.07

5.11

3.8

3.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

251

2.00

5.06

1.1

23.34

29.60

u/l

0.49

225

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

430

1.75

5.05

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

279

1.94

5.04

1.3

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

286

1.93

5.04

2.1

75.69

206.38

ug/min

0.70

(3016879) Cocaine [Presence] in Urine

132

873

1.52

5.04

2.7

1.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

574

1.65

5.03

1.1

4.41

3.70

u/ml

0.19

282

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.76

5.03

1.2

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.69

4.99

1.7

1.2

84.22

80.40

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

131

867

1.52

4.98

1.2

1.3

32.48

38.70

u/l

0.31

120

749

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.01

4.90

5.8

3.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

255

1.97

4.86

1.1

1.05

1.06

ratio

0.26

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

596

1.62

4.83

1.2

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

2.64

4.80

1.0

1.3

388.09

57.75

mu/l

0.56

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

194

1396

1.40

4.80

2.4

2.2

151.51

107.44

ug/min

0.62

115

831

(3028300) Cannabinoids [Presence] in Urine

140

949

1.49

4.77

2.6

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

139

941

1.49

4.77

2.6

1.8

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

250

1.97

4.76

1.1

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

575

1.63

4.76

1.3

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

607

1.61

4.73

5.0

7.2

7.10

7.51

mmol/l

0.72

514

(3027008) Opiates [Presence] in Urine

139

944

1.48

4.70

2.6

1.8

—

(3027944) Amphetamines [Presence] in Urine

137

930

1.48

4.65

2.7

1.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.49

4.60

1.3

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.76

4.60

1.1

1.2

0.47

0.68

umol/24h

—

(3042517) Benzodiazepines panel - Urine

5.46

4.59

2.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

4.52

4.55

2.2

1.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.81

4.54

2.1

1.6

—

(3045424) Erythrocytes [Presence] in Urine

122

813

1.51

4.53

1.5

—

(3023410) Appearance of Cerebral spinal fluid

437

1.70

4.53

1.4

1.6

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

10.01

4.51

1.3

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

10.01

4.51

7.0

8.6

—

(21494755) Public health laboratory ask at order entry panel

306

3892

0.78

4.50

1.3

1.4

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

4.82

4.49

1.6

1.3

38.76

14.59

pmol/l

0.68

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2054

18937

1.12

4.47

4.9

3.6

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

155

2.20

4.45

1.6

2.1

27.87

31.82

u/l

0.10

139

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

307

2403

1.29

4.38

2.0

1.7

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.56

4.37

1.3

1.2

83.71

73.18

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

149

1043

1.44

4.34

1.3

3.75

3.86

mmol/l

0.61

136

983

(3032057) Clostridioides difficile [Presence] in Stool

2.66

4.31

2.1

2.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

138

2.25

4.30

1.2

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

107

2.44

4.29

2.5

2.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

145

2.21

4.26

6.0

7.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

624

1.56

4.25

1.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.27

4.18

1.5

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.42

4.18

2.4

1.6

64.07

45.17

umol/l

0.69

(3034426) Prothrombin time (PT)

153

2.16

4.16

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

200

2.01

4.16

1.1

2.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

201

2.00

4.10

1.2

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

201

2.00

4.10

1.2

2.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

473

1.64

4.10

1.4

1.3

1.52

1.46

nmol/l

0.15

421

(3028717) Thiamine [Mass/volume] in Blood

3.08

4.08

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

168

2.09

4.06

1.3

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.76

4.01

1.4

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

347

1.74

4.00

1.3

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

377

1.70

4.00

1.7

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

5.56

3.97

1.0

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

124

2.26

3.95

1.0

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

120

823

1.47

3.93

1.7

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

3.13

3.92

1.3

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.26

3.90

1.5

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

472

1.62

3.89

1.2

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

125

2.25

3.88

6.6

7.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

199

1.97

3.85

1.6

1.7

3.06

4.82

nmol/l

0.61

165

(3008898) HLA-B27 [Presence]

180

1333

1.36

3.82

1.1

—

(3017569) Oxygen content in Arterial blood

250

1.85

3.78

3.1

2.3

—

(4212803) Bone marrow aspirate examination

3.19

3.77

1.1

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

643

1.52

3.76

1.1

2.75

1.87

u/ml

0.25

328

(3013336) Amino acids [Identifier] in Serum or Plasma

12.01

3.76

2.7

5.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

4.59

3.74

1.5

1.3

323.36

301.08

umol/24h

0.15

(3009871) Measles virus Ab [Titer] in Serum

134

2.17

3.72

1.6

1.7

—

(3044007) Cell count panel - Peritoneal fluid

154

2.08

3.71

1.7

1.8

—

(3025130) Human papilloma virus identified in Specimen

487

1.59

3.68

1.5

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

311

1.74

3.68

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

260

1.81

3.66

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

196

1.94

3.66

1.1

1.3

163.59

163.36

mmol/24h

0.01

196

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

283

1.77

3.62

1.7

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.51

3.60

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

374

1.66

3.59

1.7

2.0

2.88

3.51

ug/l

0.40

341

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.65

3.55

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

241

1.83

3.55

1.2

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.77

3.55

4.2

10.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.77

3.55

4.1

2.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

137

2.12

3.54

1.5

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

118

827

1.43

3.49

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

134

962

1.40

3.47

1.3

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

106

2.27

3.44

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

288

1.74

3.43

1.7

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

100

2.30

3.42

1.1

—

(44813793) Dust mix specific IgE antibody measurement

267

1.77

3.38

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

327

1.69

3.38

1.6

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

167

1.98

3.38

1.3

1177.70

298.31

ug/l

0.63

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

328

2680

1.24

3.33

2.1

1.8

—

(1761868) Lipid panel - Serum or Plasma

1660

17915

0.90

3.30

3.1

3.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.93

3.28

1.7

2.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

233

1.81

3.28

3.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

551

1.51

3.25

1.1

0.91

1.16

u/ml

0.17

240

(3036670) Protein [Mass/volume] in Synovial fluid

143

2.03

3.20

1.3

1.2

41.41

39.47

g/l

0.38

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

123

2.12

3.19

1.4

1.3

152.00

119.54

nmol/l

0.36

(3010144) Erythrocytes [#/volume] in Synovial fluid

466

1.55

3.17

1.4

103541.23

115978.65

e6/l

0.07

313

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

214

1.83

3.16

1.3

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

251

1.76

3.15

1.8

1.4

3.89

3.71

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

124

2.10

3.13

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

540

1.51

3.12

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1167

0.67

3.11

1.2

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.00

3.08

5.4

2.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

608

1.47

3.06

3.0

2.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

139

2.02

3.04

3.0

3.3

—

(3012565) Volume of 24 hour Urine

247

1.75

3.02

2.3

1896.74

1902.60

0.01

209

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.89

3.02

1.5

1.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

686

1.44

2.98

5.1

4.6

363.69

361.99

umol/l

0.04

578

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.01

2.98

1.6

5.0

—

(3052592) Norovirus Ag [Presence] in Stool

2.28

2.93

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.71

2.91

2.6

1.9

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.34

2.80

1.0

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.23

2.79

1.4

14.50

11.72

0.18

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

194

1.81

2.79

2.9

2.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.24

2.72

1.1

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

271

1.67

2.70

1.8

1.6

5.48

6.83

u/l

1.01

229

(3014271) Vancomycin [Susceptibility]

264

1.67

2.68

3.1

2.8

—

(3016750) Collection duration of Urine

304

1.62

2.63

2.3

2.0

500.53

495.10

min

0.19

213

(3019832) Treponema pallidum Ab [Presence] in Serum

272

2243

1.22

2.61

1.7

1.5

—

(3025577) Chromium [Mass/volume] in Blood

368

1.55

2.60

1.8

2.0

1.48

2.40

ug/l

2.46

308

(40757373) Influenza virus identified in Isolate

2.15

2.60

2.2

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

149

1.88

2.55

1.1

1.7

9.81

8.62

ug/l

0.73

149

(3028679) Herpes simplex virus Ab [Presence] in Serum

200

1.75

2.55

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.73

2.54

2.3

1.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.46

2.48

1.2

1.1

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

4.38

2.47

5.1

6.2

16.67

15.48

mmol/l

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.38

2.47

5.1

6.1

573.57

355.62

umol/l

—

(3035880) pH of Pleural fluid

318

1.58

2.45

1.2

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.46

2.44

1.6

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

110

2.00

2.40

2.1

1.8

—

(40768800) Prostate Pathology biopsy report

173

1374

1.27

2.36

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

418

1.49

2.35

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

477

1.45

2.32

1.7

1.5

22.31

27.68

0.67

281

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

260

1.62

2.31

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.48

2.26

6.0

8.0

—

(40768795) Lymph node Pathology biopsy report

563

1.41

2.26

1.5

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

431

1.47

2.24

1.7

1.4

0.24

0.27

nmol/l

0.25

312

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

374

1.50

2.24

1.9

1.5

0.90

0.93

g/l

0.34

374

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.11

2.22

1.1

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.86

2.20

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

250

1.60

2.14

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

128

993

1.29

2.13

2.4

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

212

1.65

2.12

1.4

1.7

2.14

5.48

ug/l

1.36

159

(3005011) Chlamydia sp Ab [Titer] in Serum

2.21

2.10

1.8

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

116

1.90

2.10

1.8

2.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

522

1.40

2.08

1.1

1.81

1.43

u/ml

0.15

267

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.56

2.07

1.1

1.3

1.45

1.76

umol/24h

0.55

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.56

2.07

1.0

2.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.56

2.07

1.0

0.00

0.44

u/ml

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

5.00

2.07

1.6

1.0

2.40

3.40

—

(3002523) Influenza virus A Ag [Presence] in Specimen

591

1.38

2.05

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

591

1.38

2.05

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.63

2.00

2.7

2.6

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.28

1.97

1.3

1.1

87.53

77.32

ug/l

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.55

1.94

1.0

2.9

—

(3050129) First trimester maternal screen panel - Serum or Plasma

424

0.59

1.93

1.4

—

(3020650) Glucose [Presence] in Urine

127

1.81

1.93

1.7

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

308

0.52

1.92

1.4

1.5

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

188

1.65

1.90

1.4

2.35

2.61

0.09

164

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.00

1.89

1.7

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

143

1.75

1.88

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.18

1.88

1.4

1.1

1.57

0.93

u/field

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.21

1.84

2.4

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

198

1.62

1.82

1.6

1.9

—

(3016018) Differential panel - Cerebral spinal fluid

502

1.38

1.81

1.3

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

123

974

1.27

1.80

2.0

1.8

185.30

203.57

pmol/l

1.28

112

913

(3029937) Albumin [Presence] in Urine by Test strip

1434

13507

1.08

1.79

5.3

3.8

0.00

estimate

2.57

595

4351

(3051593) INR in Capillary blood by Coagulation assay

263

1.52

1.78

12.3

11.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

257

1.52

1.72

4.0

2.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.85

1.71

1.2

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

171

1.64

1.70

1.3

3.90

3.21

mmol/l

0.68

154

(3039443) Prostate specific Ag panel - Serum or Plasma

1118

0.77

1.69

1.9

1.6

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.16

1.66

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

157

1.66

1.65

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

196

1.58

1.65

1.0

1.1

0.68

1.53

u/ml

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

226

0.49

1.64

1.1

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.44

1.64

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

237

1.52

1.61

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.57

1.61

2.4

4.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.69

1.58

3.4

7.0

—

(3024263) Appearance of Synovial fluid

280

1.47

1.56

1.4

1.3

—

(4034850) Laboratory test

145

1746

0.83

1.49

11.6

9.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

162

1.61

1.49

1.0

2.62

0.30

u/ml

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

218

1.52

1.48

1.3

1.4

53.61

67.17

1.30

184

(3004775) Volume in Urine collected for unspecified duration

444

1.35

1.48

2.3

2.2

685.05

632.87

0.44

286

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

195

1.54

1.45

1.0

1.1

95.60

95.36

0.01

146

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

252

1.47

1.44

1.5

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

102

1.77

1.44

1.3

1.1

—

(3013762) Body weight Measured

3.13

1.44

1.4

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

637

0.72

1.43

1.4

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.73

1.43

1.7

1.0

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

2.04

1.43

1.3

1.1

6.51

8.91

mg/l

0.35

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

755

1.26

1.41

1.1

102.98

1155.01

iu/ml

0.80

181

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.82

1.41

2.1

3.3

—

(40768793) Breast Pathology biopsy report

132

1089

1.22

1.40

1.2

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.85

1.39

1.4

1.3

108.95

195.18

ng/l

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

197

1.53

1.39

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.42

1.39

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.20

1.36

1.3

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.14

1.33

1.2

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

113

1.68

1.31

1.2

1.89

1.54

mmol/l

0.34

(3020491) Glucose [Moles/volume] in Blood

368

1.36

1.30

1.6

2.2

7.43

6.99

mmol/l

0.50

257

(3017509) Phencyclidine [Presence] in Urine

2.50

1.30

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.09

1.30

1.6

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

193

1.50

1.29

1.0

1.1

1134.62

1482.75

miu/ml

1.13

193

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

259

1.43

1.28

1.1

6.96

12.27

iu/ml

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.08

1.27

1.1

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.00

1.27

2.0

1.9

0.49

1.31

mmol/l

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.72

1.27

1.0

1.1

—

(3019174) dRVVT (LA screen)

2.29

1.26

1.0

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.29

1.26

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

280

0.61

1.26

1.6

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

100

1221

0.82

1.23

4.7

3.2

24.83

28.94

mg/l

0.66

777

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.91

1.22

1.2

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.91

1.22

1.2

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.91

1.22

1.2

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.97

1.22

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.16

1.21

1.4

1.1

5.75

19.19

u/l

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

181

1.49

1.18

1.8

1.3

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

165

1.52

1.17

1.4

31.63

19.39

0.90

154

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.70

1.17

1.1

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

110

1.64

1.15

5.4

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

103

1.65

1.12

8.5

7.1

—

(3022475) Manganese [Moles/volume] in Blood

2.33

1.12

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.00

1.12

3.1

5.5

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.90

1.12

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

158

1359

1.17

1.11

1.8

1.7

—

(44786800) Granulocytes/100 leukocytes in Body fluid

1.78

1.10

1.3

43.15

21.77

1.35

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.26

1.10

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.95

1.08

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

169

1.48

1.06

1.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

426

1.29

1.06

4.3

5.1

40.64

81.26

u/ml

1.02

124

(40765089) Chromosome analysis panel - Blood by G-banded

1.79

1.04

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

2.27

1.03

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

358

3919

0.91

1.02

1.8

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

239

1.38

1.00

1.4

1.2

49.17

56.37

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.00

1.00

1.9

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.67

0.97

1.1

1.2

1.74

1.63

mmol/l

—

(40761535) Cells panel - Urine sediment

390

4241

0.91

0.97

4.5

3.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

140

1.50

0.97

1.4

1.3

25.95

22.25

0.29

112

(3044009) aPTT.lupus sensitive (LA screen)

1.95

0.97

1.0

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.80

0.96

1.1

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

124

1.53

0.96

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

141

1.49

0.94

1.6

1.2

37.94

34.82

0.14

(3011544) Albumin [Mass/volume] in Pleural fluid

1.77

0.94

1.1

15.67

18.02

g/l

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

133

1.51

0.94

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

133

1.51

0.94

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

133

1.51

0.94

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

133

1.51

0.94

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.78

0.94

1.2

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.89

0.94

1.0

1.9

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.07

0.89

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.07

0.89

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

135

1.48

0.88

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.00

0.87

1.0

1.3

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

168

0.59

0.86

1.3

61.80

58.79

—

137

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.67

0.85

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

112

964

1.16

0.84

1.3

224.01

223.14

miu/ml

0.01

413

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

256

1.33

0.84

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.94

0.84

1.5

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

283

1.31

0.83

1.1

3.49

6.03

nmol/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

138

1.45

0.81

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

373

1.26

0.80

1.0

0.79

0.22

u/ml

0.33

118

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

267

1.31

0.80

1.5

1.8

2.81

2.89

u/field

0.02

185

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

338

1.27

0.80

1.1

1.2

42.87

44.99

mg/l

0.13

275

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

180

1609

1.12

0.79

1.8

1.7

6.88

3.36

mg/l

1.73

142

1177

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

139

1.44

0.79

1.3

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

322

1.27

0.77

1.0

1.1

291.91

303.56

mg/l

0.11

273

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.70

0.75

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.67

0.74

1.4

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.67

0.74

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

116

1.47

0.74

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

121

1374

0.88

0.72

1.1

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.75

0.71

3.0

4.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.75

0.71

3.0

2.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.55

0.69

1.0

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.85

0.68

1.6

1.8

0.66

0.71

umol/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.64

0.68

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

150

1346

1.12

0.66

4.7

3.7

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.54

0.65

1.8

2.2

1.15

1.19

mmol/l

0.85

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

234

2542

0.92

0.64

1.4

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.72

0.64

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

190

1.32

0.62

1.0

1.25

1.12

u/ml

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

424

1.20

0.62

2.1

2.0

1.82

2.00

u/field

0.11

159

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.48

0.60

2.2

3.4

48.95

111.30

ng/l

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.60

0.0

1.1

—

8.04

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

105

1.43

0.60

1.2

1.3

—

(3045716) Anion gap in Serum or Plasma

246

1.26

0.58

3.0

2.3

10.10

9.79

mmol/l

0.20

241

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

660

6324

1.05

0.55

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.45

0.55

1.2

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.58

0.54

1.5

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.47

0.50

1.1

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

472

1.17

0.50

1.3

27.82

30.95

u/l

0.25

390

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

361

1.19

0.50

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

202

0.74

0.50

1.1

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.56

0.48

1.1

1.0

—

(40765096) Chromosome analysis panel by Banding

163

1.29

0.48

1.3

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.45

0.48

2.2

3.7

31.73

42.20

umol/l

0.86

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

128

1.33

0.47

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

309

3266

0.94

0.45

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.40

0.45

2.3

2.0

16.81

20.34

umol/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.38

0.41

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.41

0.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

240

1.21

0.41

1.0

1.1

0.98

1.13

u/l

1.49

123

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.6

—

41.55

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

304

0.82

0.40

1.6

1.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.40

0.0

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.43

0.39

1.2

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.41

0.39

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

160

1.25

0.38

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

151

1.26

0.38

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.36

0.38

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.33

0.37

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

299

1.17

0.37

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

116

0.69

0.36

1.1

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

395

1.14

0.34

1.0

288.84

322.25

ng/l

0.49

273

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.33

0.33

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

296

0.84

0.32

1.5

1.4

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.28

0.32

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

398

1.13

0.32

1.0

671.75

710.40

ng/l

0.31

263

(3005033) Fetal Nuchal fold Thickness US

295

0.85

0.32

1.5

1.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.30

0.31

1.0

1.2

1.02

53.84

mg/l

—

(40762814) Titanium [Mass/volume] in Blood

101

1.29

0.31

2.1

2.3

2.30

4.77

ug/l

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

101

1.29

0.31

2.2

1.8

10.45

2.43

ug/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

399

1.13

0.31

1.0

37.75

44.67

ng/l

0.97

270

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

641

6589

0.97

0.31

4.8

4.6

32.74

32.57

0.13

463

4468

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.27

0.30

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.25

0.29

1.7

2.6

1.14

0.54

u/field

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

355

0.87

0.28

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

355

0.87

0.28

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

355

0.87

0.28

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

317

1.14

0.28

5.8

6.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

308

1.14

0.27

1.2

1.4

1.55

1.58

g/l

0.31

308

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

354

0.88

0.27

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

375

0.88

0.27

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

104

1.25

0.26

1.0

0.25

1.61

u/ml

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

141

1.21

0.26

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

106

1.23

0.23

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate

179

0.84

0.23

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

134

1.19

0.22

6.9

4.5

61.90

70.87

—

109

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

515

0.91

0.22

3.0

3.8

49.35

44.42

u/ml

0.09

507

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

229

1.14

0.21

1.3

1.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.19

0.21

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.20

0.0

1.3

—

9.90

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.22

0.20

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

261

1.11

0.18

9.2

5.3

41.00

239.80

u/ml

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.11

0.17

1.6

1.3

71.27

74.74

—

(3036048) Francisella tularensis Ab [Titer] in Serum

101

1.19

0.16

1.2

1.1

—

240.00

—

(3024869) Neuronal Ab [Presence] in Serum

111

1.17

0.15

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.76

0.15

1.3

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

528

1.06

0.14

3.7

3.1

32.73

57.22

mg/l

0.68

393

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

122

1.15

0.13

1.1

2.8

7.07

7.80

mmol/l

0.39

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

170

1.12

0.13

1.4

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

109

0.83

0.13

5.9

7.4

—

(3035933) Granulocytes/100 leukocytes in Blood

110

0.82

0.13

1.1

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

545

5370

1.02

0.12

1.6

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

262

0.92

0.12

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.16

0.11

1.0

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

455

1.06

0.11

1.0

1.1

2.55

2.99

u/ml

0.11

225

(3006270) Folate [Moles/volume] in Blood

416

1.06

0.11

1.0

1.2

343.46

361.71

nmol/l

0.25

346

(3023430) Cat dander IgE Ab [Units/volume] in Serum

417

1.06

0.10

1.0

1.1

5.93

2.80

u/ml

0.45

168

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

145

1.10

0.09

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.83

0.08

6.0

8.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.09

0.08

2.0

1.5

—

(3019150) Specific gravity of Urine by Refractometry

1061

10680

0.99

0.08

4.9

3.9

1.02

kg/l

0.28

179

1494

(40758292) HTLV I+II Ab panel - Serum

1.07

0.07

1.4

1.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

235

1.06

0.07

1.3

5.84

6.10

mmol/l

0.58

223

(1617658) Protocol used for examination of sentinel lymph nodes

395

1.04

0.05

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

110

1.09

0.05

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

352

0.97

0.04

1.5

1.3

151.50

192.65

pmol/l

0.63

352

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

181

1.05

0.03

2.9

2.8

31.08

28.97

umol/l

0.37

135

(3022689) Creatine [Moles/volume] in Urine

148

0.95

0.02

2.1

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

204

2054

0.99

0.02

1.6

1.7

—

(4146454) Self-monitoring of blood glucose

582

1.01

0.01

2.9

2.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

112

0.98

0.00

1.2

1.3

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.54

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

171.80

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

2.69

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.00

-0.00

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

1.27

—

(3014891) Appearance of Pleural fluid

0.99

-0.00

1.1

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.00

-0.00

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

31.00

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OTHINT and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_OTHINT	2.269 [2.0, 2.57]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.275

During the follow-up period (1.1.1998 — 31.12.2019), 2745 out of 8346 females with K11_OTHINT died.

Males

Parameter	HR [95% CI]	p-value
K11_OTHINT	2.521 [2.18, 2.92]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.008

During the follow-up period (1.1.1998 — 31.12.2019), 2777 out of 8156 males with K11_OTHINT died.

Mortality risk

Mortality risk for people of age

years, who have K11_OTHINT.

N-year risk	Females	Males
1	0.175%	0.453%
5	1.332%	2.727%
10	3.489%	6.975%
15	6.572%	13.4%
20	11.598%	22.801%

Relationships between endpoints

↥

Index endpoint: K11_OTHINT – Other diseases of intestine

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other diseases of intestine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints